| 1 | I-123-5-IA85380 | - | - | - | - | [1] 6 6 💬
|
| 2 | I-FACTOR | - | - | - | - | [1] 70 70 💬
|
| 3 | I-Neb AAD system | - | - | - | - | [1] 86 86 💬
|
| 4 | I.v. immunoglobulins | - | - | - | - | [1] 151 151 💬
|
| 5 | I.v. recombinant human C1 inhibitor | - | - | - | - | [1] 65 65 💬
|
| 6 | I.v. selexipag | [1] Selexipag Selexipag | [1] Selexipag
Selexipag
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 7 | I10 | - | - | - | - | [1] 14 14 💬
|
| 8 | I10E | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 9 | I2S | - | - | - | - | [1] 19 19 💬
|
| 10 | I2S-IT | - | - | - | - | [1] 19 19 💬
|
| 11 | IA-14069 | - | - | - | - | [1] 46 46 💬
|
| 12 | Ianalumab | [1] Ianalumab Ianalumab | [1] Ianalumab
Ianalumab
💬
| [1] TNFRSF13C TNFRSF13C 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬 | [8] 35 35, 46, 49, 51, 53, 61, 63, 95 💬
|
| 13 | Ianalumab (VAY736) | [1] Ianalumab Ianalumab | [1] Ianalumab
Ianalumab
💬
| [1] TNFRSF13C TNFRSF13C 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬 | [1] 53 53 💬
|
| 14 | IanalumabProduct Code: VAY736Pharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: IanalumabCurrent Sponsor code: VAY736Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Concentrate for solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [2] 61 61, 63 💬
|
| 15 | IanalumabProduct Code: VAY736Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: IANALUMABCAS Number: 1929549-92-7Current Sponsor code: VAY736Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 53 53 💬
|
| 16 | IASO-782 injection | - | - | - | - | [2] 49 49, 61 💬
|
| 17 | IASO206 injection | - | - | - | - | [1] 61 61 💬
|
| 18 | IB 1001 | - | - | - | - | [1] 65 65 💬
|
| 19 | IB-MECA | - | - | - | - | [1] 46 46 💬
|
| 20 | IB1001 | - | - | - | - | [2] 19 19, 65 💬
|
| 21 | Ibandronate | [1] Ibandronate Ibandronate | [2] Ibandronate sodium
Ibandronate sodium
,
Ibandronic acid
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [2] 46 46, 49 💬
|
| 22 | Ibandronate+alfacalcidol+calcium | [3] Alfacalcidol Alfacalcidol, Calcium, Ibandronate | [3] Alfacalcidol
Alfacalcidol
,
Ibandronate sodium
,
Ibandronic acid
💬
| [2] FDPS FDPS, VDR 💬
| [8] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis 💬 | [1] 49 49 💬
|
| 23 | Ibandronic acid | - | - | - | - | [1] 274 274 💬
|
| 24 | IBD-AID diet combined with Kate Farms Peptide 1.5 | - | - | - | - | [1] 96 96 💬
|
| 25 | IBD98-M | - | - | - | - | [1] 97 97 💬
|
| 26 | IBD98-M Delayed-release Capsules | - | - | - | - | [1] 97 97 💬
|
| 27 | IBEROGAST | - | - | - | - | [1] 6 6 💬
|
| 28 | Iberogast N | - | - | - | - | [1] 97 97 💬
|
| 29 | IBI303 | - | - | - | - | [1] 271 271 💬
|
| 30 | IBI306 | - | - | - | - | [1] 79 79 💬
|
| 31 | IBI306 450mg SC Q4W | - | - | - | - | [1] 79 79 💬
|
| 32 | IBI306 600mg SC Q6W | - | - | - | - | [1] 79 79 💬
|
| 33 | IBI355 | - | - | - | - | [1] 53 53 💬
|
| 34 | Ibrutinib | [1] Ibrutinib Ibrutinib | [1] Ibrutinib
Ibrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [3] 28 28, 60, 61 💬
|
| 35 | Ibrutinib 420 mg | [1] Ibrutinib Ibrutinib | [1] Ibrutinib
Ibrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 61 61 💬
|
| 36 | IBUDILAST | [1] Ibudilast Ibudilast | [1] Ibudilast
Ibudilast
💬
| [8] CYSLTR1 CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR 💬
| [15] Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 2 2, 13 💬
|
| 37 | Ibuprofen | [1] Ibuprofen Ibuprofen | [5] Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [8] 13 13, 46, 65, 96, 107, 113, 271, 299 💬
|
| 38 | IBUPROFEN 200MG | [1] Ibuprofen Ibuprofen | [5] Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 113 113 💬
|
| 39 | Ibuprofen Sandoz 400 mg Filmtabletten | [1] Ibuprofen Ibuprofen | [5] Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 💬
|
| 40 | IC Cocktail | - | - | - | - | [1] 226 226 💬
|
| 41 | IC14 | - | - | - | - | [1] 2 2 💬
|
| 42 | ICA07 therapy | - | - | - | - | [1] 6 6 💬
|
| 43 | ICaspase9-transduced T cells | - | - | - | - | [1] 65 65 💬
|
| 44 | ICATIBANT | [1] Icatibant Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 45 | Icatibant (30 mg) | [1] Icatibant Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 46 | ICATIBANT ACETATE | [2] Acetate Acetate, Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 47 | Icatibant Acetate (JAN) | [2] Acetate Acetate, Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 48 | Icatibant acetate solution for injection 10 mg/ml | [2] Acetate Acetate, Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 49 | Icatibant Injection (Icanticure®) | [1] Icatibant Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 50 | Icenticaftor | [1] Icenticaftor Icenticaftor | [1] Icenticaftor
Icenticaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 51 | Icerguastat | [1] Icerguastat Icerguastat | - | - | - | [1] 2 2 💬
|
| 52 | ICG | - | - | - | - | [3] 93 93, 94, 235 💬
|
| 53 | ICG Pulsion | - | - | - | - | [1] 296 296 💬
|
| 54 | ICG-guided bowel perfusion assessment | - | - | - | - | [1] 96 96 💬
|
| 55 | ICG-Pulsion | - | - | - | - | [1] 46 46 💬
|
| 56 | ICG-Pulsion 25mg | - | - | - | - | [1] 296 296 💬
|
| 57 | ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T | - | - | - | - | [1] 97 97 💬
|
| 58 | ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T following cyclophosphamide-only lymphodepletion | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 49 49 💬
|
| 59 | ICI 182,780 (Faslodex) | - | - | - | - | [1] 49 49 💬
|
| 60 | ICL670 | - | - | - | - | [3] 60 60, 284, 286 💬
|
| 61 | Icosapent | [1] Icosapent Icosapent | [1] Icosapent
Icosapent
💬
| - | - | [1] 8 8 💬
|
| 62 | Icotinib | [1] Icotinib Icotinib | [1] Icotinib
Icotinib
💬
| [1] EGFR EGFR 💬
| [49] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬 | [1] 34 34 💬
|
| 63 | Icotrokinra | [1] Icotrokinra Icotrokinra | [1] Icotrokinra
Icotrokinra
💬
| [1] IL23R IL23R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th17 cell differentiation 💬 | [2] 96 96, 97 💬
|
| 64 | ICP-022 | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 65 | ICS+LABA | - | - | - | - | [1] 299 299 💬
|
| 66 | ICX-RHY | [1] ICX-RHY ICX-RHY | - | - | - | [1] 36 36 💬
|
| 67 | ICX-RHY-013 | [1] ICX-RHY ICX-RHY | - | - | - | [1] 36 36 💬
|
| 68 | Idebenone | [1] Idebenone Idebenone | [1] Idebenone
Idebenone
💬
| - | - | [9] 6 6, 8, 13, 17, 18, 21, 113, 115, 302 💬
|
| 69 | Idebenone 150 mg film-coated tablets | [1] Idebenone Idebenone | [1] Idebenone
Idebenone
💬
| - | - | [1] 113 113 💬
|
| 70 | IDEC-C2B8 (rituximab) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 71 | IDEC-C2B8, Ro 45-2294 | - | - | - | - | [1] 64 64 💬
|
| 72 | Idecabtagene vicleucel | [1] Idecabtagene vicleucel Idecabtagene vicleucel | [1] Idecabtagene vicleucel
Idecabtagene vicleucel
💬
| [1] TNFRSF17 TNFRSF17 💬
| [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production 💬 | [1] 28 28 💬
|
| 73 | Idefirix | - | - | - | - | [3] 43 43, 44, 113 💬
|
| 74 | Identical Tacrolimus-free Lipid Suspension for Enema | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 75 | IdeS | - | - | - | - | [1] 64 64 💬
|
| 76 | IdeS (0.25 mg/kg) | - | - | - | - | [1] 64 64 💬
|
| 77 | IdeS (0.50 mg/kg) | - | - | - | - | [1] 64 64 💬
|
| 78 | IDL-2965 Oral Capsule | - | - | - | - | [1] 85 85 💬
|
| 79 | IDMT | - | - | - | - | [1] 13 13 💬
|
| 80 | IDOFORM®Travel | - | - | - | - | [1] 97 97 💬
|
| 81 | IDP-023 | - | - | - | - | [1] 13 13 💬
|
| 82 | IDPM | - | - | - | - | [1] 299 299 💬
|
| 83 | IDPM: Inhaled Dry Powder Mannitol | [1] Mannitol Mannitol | [1] Mannitol
Mannitol
💬
| - | - | [1] 299 299 💬
|
| 84 | IDROCORTISONE | - | - | - | - | [1] 81 81 💬
|
| 85 | IDROCORTISONE ACETATO | - | - | - | - | [1] 97 97 💬
|
| 86 | IDROCORTISONE ACETATO DYNACREN - 1 % CREMA 1 TUBO DA 30 G | - | - | - | - | [1] 272 272 💬
|
| 87 | IDROCORTISONE ACETATO DYNACREN 1% CREMA | - | - | - | - | [1] 272 272 💬
|
| 88 | Idrossiclorochina solfato | - | - | - | - | [1] 51 51 💬
|
| 89 | Iduronate-2-sulfatase enzyme replacement therapy | - | - | - | - | [1] 19 19 💬
|
| 90 | IDURONATE-2-SULFATASE FUSED TO A FC POLYPEPTIDE THAT BINDS TO THE HUMAN TRANSFERRIN RECEPTOR | - | - | - | - | [1] 19 19 💬
|
| 91 | IDURSULFASA | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 92 | IDURSULFASE | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 93 | Idursulfase (ELAPRASE) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 94 | Idursulfase (I2S) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 95 | Idursulfase (I2S)-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 96 | Idursulfase beta | [2] Idursulfase Idursulfase, Idursulfase beta | [2] Idursulfase
Idursulfase
,
Idursulfase beta
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 97 | Idursulfase IT (1 mg) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 98 | Idursulfase IT (10 mg) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 99 | Idursulfase IT (30 mg) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 100 | Idursulfase(12S)-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 101 | Idursulfase(I2S)-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 102 | Idursulfase-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 103 | IDURSULFASI | - | - | - | - | [1] 19 19 💬
|
| 104 | IFA Incomplete Freund's Adjuvant | - | - | - | - | [1] 13 13 💬
|
| 105 | IFB-088 | - | - | - | - | [1] 2 2 💬
|
| 106 | IFB-088 50mg/day | - | - | - | - | [1] 2 2 💬
|
| 107 | Ifenprodil | [1] Ifenprodil Ifenprodil | [2] Ifenprodil tartrate
Ifenprodil tartrate
,
Ifenprodil
💬
| [3] ADRA1A ADRA1A, ADRA1B, ADRA1D 💬
| [9] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 108 | Ifetroban | [1] Ifetroban Ifetroban | [2] Ifetroban
Ifetroban
,
Ifetroban sodium
💬
| [1] TBXA2R TBXA2R 💬
| [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | [4] 51 51, 85, 86, 113 💬
|
| 109 | Ifetroban Sodium | [1] Ifetroban Ifetroban | [2] Ifetroban
Ifetroban
,
Ifetroban sodium
💬
| [1] TBXA2R TBXA2R 💬
| [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | [1] 85 85 💬
|
| 110 | IFN beta 1a 44 mcg TIW | - | - | - | - | [1] 13 13 💬
|
| 111 | IFN beta-1a | - | - | - | - | [1] 13 13 💬
|
| 112 | IFN ß-1a | - | - | - | - | [1] 13 13 💬
|
| 113 | IFN-a 2b Kinoid Drug Substance | - | - | - | - | [1] 49 49 💬
|
| 114 | IFN-a2b Kinoid | - | - | - | - | [1] 49 49 💬
|
| 115 | IFN-beta-1a (Rebif®) | - | - | - | - | [1] 13 13 💬
|
| 116 | IFN-beta-1a, (Avonex®) | - | - | - | - | [1] 13 13 💬
|
| 117 | IFN-gamma | - | - | - | - | [1] 65 65 💬
|
| 118 | IFN-K | - | - | - | - | [2] 49 49, 50 💬
|
| 119 | IFN-Kinoid | - | - | - | - | [2] 49 49, 50 💬
|
| 120 | IFN-Kinoid Drug Substance | - | - | - | - | [2] 49 49, 50 💬
|
| 121 | IFN-ß-1a (Rebif®) | - | - | - | - | [1] 13 13 💬
|
| 122 | IFN-ß-1a, (Avonex®) | - | - | - | - | [1] 13 13 💬
|
| 123 | IFNa-Kinoid | - | - | - | - | [2] 49 49, 50 💬
|
| 124 | Ifosfamide | [1] Ifosfamide Ifosfamide | [1] Ifosfamide
Ifosfamide
💬
| - | - | [1] 34 34 💬
|
| 125 | IFX-1 | [1] Vilobelimab Vilobelimab | [1] Vilobelimab
Vilobelimab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 43 43, 44, 269 💬
|
| 126 | Ig VENA | - | - | - | - | [2] 50 50, 63 💬
|
| 127 | Ig VENA (10g/200mL) | - | - | - | - | [1] 50 50 💬
|
| 128 | Ig VENA 100 ml vial | - | - | - | - | [1] 63 63 💬
|
| 129 | Ig VENA 50 g/l solution for infusion 100 ml vial + infusion set | - | - | - | - | [2] 63 63, 65 💬
|
| 130 | IGE025 | - | - | - | - | [1] 299 299 💬
|
| 131 | IGF-1 | - | - | - | - | [1] 113 113 💬
|
| 132 | IgG IL2/RO7049665 | - | - | - | - | [1] 95 95 💬
|
| 133 | IgG Next Generation | - | - | - | - | [2] 63 63, 65 💬
|
| 134 | IgG Next Generation (BT595) | - | - | - | - | [1] 65 65 💬
|
| 135 | IGG2 ANTIBODIES | - | - | - | - | [2] 96 96, 97 💬
|
| 136 | IgG2/4? | - | - | - | - | [1] 109 109 💬
|
| 137 | IgHy10 | - | - | - | - | [1] 65 65 💬
|
| 138 | IGIV GAMMAGARD LIQUID/KIOVIG | - | - | - | - | [1] 14 14 💬
|
| 139 | IGIV GAMUNEX®-C | - | - | - | - | [1] 14 14 💬
|
| 140 | IGIV, 10% | - | - | - | - | [2] 14 14, 65 💬
|
| 141 | IGIV-C | - | - | - | - | [1] 11 11 💬
|
| 142 | IGIV-C 10% | - | - | - | - | [1] 65 65 💬
|
| 143 | IGIV3I Grifols | - | - | - | - | [1] 63 63 💬
|
| 144 | IGIV3I Grifols 10% | - | - | - | - | [1] 63 63 💬
|
| 145 | IgNextGen 10% | - | - | - | - | [1] 63 63 💬
|
| 146 | IgNextGen 16% | - | - | - | - | [1] 65 65 💬
|
| 147 | IGNG | - | - | - | - | [1] 65 65 💬
|
| 148 | IgPro | - | - | - | - | [1] 65 65 💬
|
| 149 | IgPro10 | - | - | - | - | [4] 14 14, 51, 63, 65 💬
|
| 150 | IgPro20 | - | - | - | - | [4] 14 14, 50, 51, 65 💬
|
| 151 | IgPro20 (high dose) | - | - | - | - | [1] 14 14 💬
|
| 152 | IgPro20 (low dose) | - | - | - | - | [1] 14 14 💬
|
| 153 | IGSC 20% | - | - | - | - | [1] 65 65 💬
|
| 154 | IGSC 20% 150 mg/kg | - | - | - | - | [1] 65 65 💬
|
| 155 | IGSC 20% daily push versus 2 times per week pump | - | - | - | - | [1] 65 65 💬
|
| 156 | IGSC 20% daily push versus every 2 weeks pump | - | - | - | - | [1] 65 65 💬
|
| 157 | IGSC 20% daily push versus once a week pump | - | - | - | - | [1] 65 65 💬
|
| 158 | IGSC 20% infusion | - | - | - | - | [1] 65 65 💬
|
| 159 | IGSC, 16% | - | - | - | - | [1] 65 65 💬
|
| 160 | IGSC, 20% | - | - | - | - | [1] 65 65 💬
|
| 161 | IGT001 | - | - | - | - | [1] 90 90 💬
|
| 162 | Iguratimod | [1] Iguratimod Iguratimod | [1] Iguratimod
Iguratimod
💬
| [1] NFKB1 NFKB1 💬
| [76] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬 | [7] 46 46, 49, 51, 53, 63, 271, 300 💬
|
| 163 | Iguratimod Tablets | [1] Iguratimod Iguratimod | [1] Iguratimod
Iguratimod
💬
| [1] NFKB1 NFKB1 💬
| [76] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬 | [2] 46 46, 53 💬
|
| 164 | IGVENA*FL 200ML 10G+SET | - | - | - | - | [2] 14 14, 50 💬
|
| 165 | IgY | - | - | - | - | [1] 299 299 💬
|
| 166 | IHL-675A | - | - | - | - | [1] 46 46 💬
|
| 167 | IHMA-2121771-1 | - | - | - | - | [1] 299 299 💬
|
| 168 | IHMA-2121771-2 | - | - | - | - | [1] 299 299 💬
|
| 169 | IHMA-2121908-1 | - | - | - | - | [1] 299 299 💬
|
| 170 | Ikervis | - | - | - | - | [1] 53 53 💬
|
| 171 | IKT-001 | - | - | - | - | [1] 86 86 💬
|
| 172 | IKT-001Pro | [1] IKT-001Pro IKT-001Pro | - | - | - | [1] 86 86 💬
|
| 173 | IkT-148009 | - | - | - | - | [1] 6 6 💬
|
| 174 | IL-1 Trap | - | - | - | - | [1] 266 266 💬
|
| 175 | IL-2 | - | - | - | - | [3] 2 2, 49, 51 💬
|
| 176 | IL-2 Low dose | - | - | - | - | [1] 222 222 💬
|
| 177 | IL-23 inhibitor | - | - | - | - | [1] 96 96 💬
|
| 178 | IL-23 Therapy | - | - | - | - | [1] 96 96 💬
|
| 179 | IL-6 receptor inhibitor, humanized monoclonal antibody | - | - | - | - | [1] 46 46 💬
|
| 180 | IL-6 receptor inhibitor, recombinant humanized monoclonal antibody | - | - | - | - | [2] 46 46, 107 💬
|
| 181 | IL-6R Monoclonal Antibody Injection 4mg/kg | - | - | - | - | [1] 46 46 💬
|
| 182 | IL-6R Monoclonal Antibody Injection 6mg/kg | - | - | - | - | [1] 46 46 💬
|
| 183 | IL-6R Monoclonal Antibody Injection 8mg/kg | - | - | - | - | [1] 46 46 💬
|
| 184 | IL-6R nanobody | - | - | - | - | [1] 49 49 💬
|
| 185 | IL2 | - | - | - | - | [1] 13 13 💬
|
| 186 | IL6 inhibitor | - | - | - | - | [1] 51 51 💬
|
| 187 | Ilaris | - | - | - | - | [8] 54 54, 56, 84, 106, 107, 108, 266, 267 💬
|
| 188 | Ilaris® | - | - | - | - | [1] 54 54 💬
|
| 189 | ILB | - | - | - | - | [1] 2 2 💬
|
| 190 | ILB: 100mg/ml solution for injection and infusion | - | - | - | - | [1] 2 2 💬
|
| 191 | ILB® | - | - | - | - | [1] 2 2 💬
|
| 192 | Ileocecal resection | - | - | - | - | [1] 96 96 💬
|
| 193 | Ileocolonic biopsies | - | - | - | - | [1] 96 96 💬
|
| 194 | Ileocolonoscopy | - | - | - | - | [1] 96 96 💬
|
| 195 | Ilofotase Alfa, 0.8 mg/kg | - | - | - | - | [1] 172 172 💬
|
| 196 | Ilofotase Alfa, 3.2 mg/kg | - | - | - | - | [1] 172 172 💬
|
| 197 | Ilomedin | - | - | - | - | [1] 51 51 💬
|
| 198 | Ilomedin 20 | - | - | - | - | [1] 86 86 💬
|
| 199 | Ilomedin 20 [20 µg / ml] | - | - | - | - | [1] 86 86 💬
|
| 200 | Iloperidone | [1] Iloperidone Iloperidone | [1] Iloperidone
Iloperidone
💬
| [4] DRD2 DRD2, HTR2A, HTR2B, HTR2C 💬
| [13] Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 201 | Iloprost | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [4] 51 51, 84, 85, 86 💬
|
| 202 | Iloprost (5 µg) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 203 | Iloprost (Ventavis BAYQ6256) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 204 | Iloprost (Ventavis inhaled, BAYQ6256) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 205 | Iloprost (Ventavis, BAYQ 6256) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 206 | Iloprost (Ventavis, BAYQ6256) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 207 | Iloprost (Ventavis®) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 208 | Iloprost Inhalation Solution (Ventavis) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [2] 85 85, 86 💬
|
| 209 | Iloprost Injection, for intravenous use | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 210 | Iloprost low dose | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 211 | Iloprost PD-15 | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 212 | Iloprost PD-6 | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 213 | ILOPROST SALE DI TROMETAMOLO | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 214 | Iloprost therapy up to 2 ng/kg x min | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 215 | ILOPROST TROMETAMOL | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 216 | Iloprost,(Ventavis, BAYQ6256) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 217 | ILT-101 | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 49 49 💬
|
| 218 | Ilumetri | - | - | - | - | [1] 271 271 💬
|
| 219 | Iluvien | - | - | - | - | [1] 90 90 💬
|
| 220 | ILV-094 | - | - | - | - | [1] 46 46 💬
|
| 221 | IM-101 Part A | - | - | - | - | [1] 11 11 💬
|
| 222 | IM-101 Part B | - | - | - | - | [1] 11 11 💬
|
| 223 | IM19 CAR-T cells | - | - | - | - | [1] 49 49 💬
|
| 224 | IM90838 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 225 | Imaging and Clinical Reports | - | - | - | - | [1] 2 2 💬
|
| 226 | Imatimib Mesylate | - | - | - | - | [1] 89 89 💬
|
| 227 | Imatinib | [1] Imatinib Imatinib | [2] Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| [3] ABL1 ABL1, KIT, PDGFRA 💬
| [34] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [12] 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
|
| 228 | IMATINIB MESILATE | [1] Imatinib Imatinib | [2] Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| [3] ABL1 ABL1, KIT, PDGFRA 💬
| [34] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [3] 13 13, 86, 88 💬
|
| 229 | IMATINIB MESILATO | [1] Imatinib Imatinib | [2] Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| [3] ABL1 ABL1, KIT, PDGFRA 💬
| [34] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 51 51 💬
|
| 230 | Imatinib Mesylate | [1] Imatinib Imatinib | [2] Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| [3] ABL1 ABL1, KIT, PDGFRA 💬
| [34] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [5] 13 13, 28, 34, 51, 86 💬
|
| 231 | Imatinib Mesylate (Gleevec) | [1] Imatinib Imatinib | [2] Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| [3] ABL1 ABL1, KIT, PDGFRA 💬
| [34] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 85 85 💬
|
| 232 | Imatinib Mesylate 400Mg Capsule | [1] Imatinib Imatinib | [2] Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| [3] ABL1 ABL1, KIT, PDGFRA 💬
| [34] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 89 89 💬
|
| 233 | IMB-1018972 | - | - | - | - | [1] 58 58 💬
|
| 234 | IMC-002 | - | - | - | - | [1] 13 13 💬
|
| 235 | IMC-002 + SOC | - | - | - | - | [1] 49 49 💬
|
| 236 | IMC-003 and PAH background therapy | - | - | - | - | [1] 86 86 💬
|
| 237 | IMCY-0141 | [1] IMCY-0141 IMCY-0141 | - | - | - | [1] 13 13 💬
|
| 238 | IMD Preparative Regimen | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 239 | Imeroprubart | - | - | - | - | [1] 14 14 💬
|
| 240 | IMETH | - | - | - | - | [1] 46 46 💬
|
| 241 | Imidapril | [1] Imidapril Imidapril | [2] Imidapril hydrochloride
Imidapril hydrochloride
,
Imidapril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 67 67 💬
|
| 242 | Imidazole | [1] Imidazole Imidazole | - | - | - | [1] 21 21 💬
|
| 243 | IMIGLUCERASA | - | - | - | - | [1] 19 19 💬
|
| 244 | IMIGLUCERASE | [1] Imiglucerase Imiglucerase | [2] Alglucerase
Alglucerase
,
Imiglucerase
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 245 | Imiglucerase GZ437843 | [1] Imiglucerase Imiglucerase | [2] Alglucerase
Alglucerase
,
Imiglucerase
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 246 | IMIGLUCERASI | - | - | - | - | [1] 19 19 💬
|
| 247 | Imiglucérase (drug) pharmacokinetics | - | - | - | - | [1] 19 19 💬
|
| 248 | IMIPENEM | [1] Imipenem Imipenem | [2] Imipenem
Imipenem
,
Imipenem
💬
| - | - | [3] 60 60, 296, 299 💬
|
| 249 | Imipenem + Cilastatin | [2] Cilastatin Cilastatin, Imipenem | [4] Imipenem
Imipenem
,
Cilastatin sodium
,
Imipenem
,
Cilastatin
💬
| - | - | [1] 299 299 💬
|
| 250 | Imipenem / cilastatine | [2] Cilastatin Cilastatin, Imipenem | [4] Imipenem
Imipenem
,
Cilastatin sodium
,
Imipenem
,
Cilastatin
💬
| - | - | [1] 60 60 💬
|
| 251 | Imipenem-cilastatine | [2] Cilastatin Cilastatin, Imipenem | [4] Imipenem
Imipenem
,
Cilastatin sodium
,
Imipenem
,
Cilastatin
💬
| - | - | [1] 60 60 💬
|
| 252 | Imipenem/Cilastatin/Relebactam | [3] Cilastatin Cilastatin, Imipenem, Relebactam | [5] Imipenem
Imipenem
,
Cilastatin sodium
,
Imipenem
,
Cilastatin
,
Relebactam
💬
| - | - | [1] 299 299 💬
|
| 253 | Imiquimod | [1] Imiquimod Imiquimod | [1] Imiquimod
Imiquimod
💬
| [1] TLR7 TLR7 💬
| [6] Coronavirus disease Coronavirus disease, Influenza A, Lysosome biogenesis, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [2] 34 34, 51 💬
|
| 254 | Imiquimod 5% Cream | [1] Imiquimod Imiquimod | [1] Imiquimod
Imiquimod
💬
| [1] TLR7 TLR7 💬
| [6] Coronavirus disease Coronavirus disease, Influenza A, Lysosome biogenesis, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [2] 34 34, 51 💬
|
| 255 | Imitation Procedure | - | - | - | - | [1] 20 20 💬
|
| 256 | Imlifidase | [1] Imlifidase Imlifidase | [1] Imlifidase
Imlifidase
💬
| - | - | [4] 43 43, 44, 113, 221 💬
|
| 257 | Imlygic | - | - | - | - | [1] 34 34 💬
|
| 258 | IMM0306 | - | - | - | - | [1] 300 300 💬
|
| 259 | Immediate post operative bioassay of Parathyroid Hormone | [1] Parathyroid hormone Parathyroid hormone | [1] Parathyroid hormone
Parathyroid hormone
💬
| [2] PTH1R PTH1R, PTH2R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 260 | Immediate release carbidopa/levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 261 | Immediate Release carbidopa/levodopa 10/100 mg | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 262 | Immediate Release carbidopa/levodopa 25/100 mg | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 263 | Immediate Release Melatonin | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬
| [2] MTNR1A MTNR1A, MTNR1B 💬
| [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬
|
| 264 | Immediate treatment with corticosteroids | - | - | - | - | [1] 11 11 💬
|
| 265 | Immediate-Release Tablets | - | - | - | - | [1] 11 11 💬
|
| 266 | IMMU-103 | - | - | - | - | [1] 49 49 💬
|
| 267 | Immukin | - | - | - | - | [1] 85 85 💬
|
| 268 | Immune Ablation and Hematopoietic Stem Cell Support | - | - | - | - | [1] 96 96 💬
|
| 269 | Immune ablation and hematopoietic stem cell support. | - | - | - | - | [1] 49 49 💬
|
| 270 | Immune ablation and hematopoietic stem cell transplant | - | - | - | - | [1] 46 46 💬
|
| 271 | Immune Checkpoint Inhibitors | - | - | - | - | [3] 25 25, 51, 53 💬
|
| 272 | Immune globulin | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 273 | Immune globulin (human) 10% solution for intravenous administration | - | - | - | - | [1] 14 14 💬
|
| 274 | Immune Globulin (Human), 10% Caprylate/Chromatography Purified | - | - | - | - | [1] 11 11 💬
|
| 275 | Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) | - | - | - | - | [1] 11 11 💬
|
| 276 | Immune Globulin 10% Intravenous Solution | - | - | - | - | [1] 14 14 💬
|
| 277 | Immune Globulin Infusion (Human), 10% | - | - | - | - | [1] 65 65 💬
|
| 278 | Immune Globulin Intravenous | - | - | - | - | [1] 65 65 💬
|
| 279 | Immune Globulin Intravenous (Human) | - | - | - | - | [2] 50 50, 65 💬
|
| 280 | Immune Globulin Intravenous (Human) 5% Liquid, IVIG-SN™ | - | - | - | - | [1] 65 65 💬
|
| 281 | Immune Globulin Intravenous (human), 10% | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 282 | Immune Globulin Intravenous (Human), 10% Solution | - | - | - | - | [1] 65 65 💬
|
| 283 | Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution | - | - | - | - | [1] 63 63 💬
|
| 284 | Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution | - | - | - | - | [1] 65 65 💬
|
| 285 | Immune Globulin Intravenous (IGIV) | - | - | - | - | [1] 65 65 💬
|
| 286 | Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified | - | - | - | - | [1] 65 65 💬
|
| 287 | Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified | - | - | - | - | [1] 14 14 💬
|
| 288 | Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified | - | - | - | - | [1] 13 13 💬
|
| 289 | Immune Globulin Subcutaneos, 20% | - | - | - | - | [1] 65 65 💬
|
| 290 | Immune Globulin Subcutaneous (Human) | - | - | - | - | [2] 14 14, 65 💬
|
| 291 | Immune Globulin Subcutaneous (Human) (SCIG) | - | - | - | - | [1] 65 65 💬
|
| 292 | Immune Globulin Subcutaneous (Human), 20% | - | - | - | - | [1] 65 65 💬
|
| 293 | Immune Globulin Subcutaneous (Human), 20% Caprylate/Chromatography Purified (IGSC 20%) | - | - | - | - | [1] 65 65 💬
|
| 294 | Immune Globulin Subcutaneous (Human), 20% Solution | - | - | - | - | [1] 65 65 💬
|
| 295 | Immune Globulin Subcutaneous (Human), 20%, Caprylate/Chromatography Purified | - | - | - | - | [1] 65 65 💬
|
| 296 | Immune Globulin Subcutaneous, 20% | - | - | - | - | [1] 65 65 💬
|
| 297 | Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%) | - | - | - | - | [1] 65 65 💬
|
| 298 | Immune Suppressant | - | - | - | - | [1] 66 66 💬
|
| 299 | Immunglobulin | - | - | - | - | [1] 63 63 💬
|
| 300 | Immunglobulin (human) | - | - | - | - | [1] 65 65 💬
|
| 301 | Immunoadsorption | - | - | - | - | [2] 13 13, 14 💬
|
| 302 | Immunoglobulin | - | - | - | - | [3] 13 13, 14, 63 💬
|
| 303 | Immunoglobulin (Hizentra) | - | - | - | - | [1] 50 50 💬
|
| 304 | IMMUNOGLOBULIN G | - | - | - | - | [9] 2 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
|
| 305 | Immunoglobulin G (Ig NextGen 16%) | - | - | - | - | [1] 65 65 💬
|
| 306 | Immunoglobulin G cleaving cystein protease derived from E. coli | - | - | - | - | [2] 43 43, 44 💬
|
| 307 | Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy | - | - | - | - | [1] 2 2 💬
|
| 308 | Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy chain), disulfide with human Mus musculus monoclonal light chain, dimer | - | - | - | - | [1] 2 2 💬
|
| 309 | Immunoglobulin G1, anti-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer | - | - | - | - | [1] 49 49 💬
|
| 310 | Immunoglobulin Intravenous (Human) | - | - | - | - | [2] 63 63, 65 💬
|
| 311 | Immunoglobulin IV | - | - | - | - | [1] 222 222 💬
|
| 312 | Immunoglobulin perfusion | - | - | - | - | [1] 14 14 💬
|
| 313 | IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI | - | - | - | - | [1] 51 51 💬
|
| 314 | Immunoglobulina normale umana | - | - | - | - | [2] 14 14, 51 💬
|
| 315 | Immunoglobulina Normale Umana per somministrazione endovenosa | - | - | - | - | [1] 51 51 💬
|
| 316 | Immunoglobulina Normale Umana per somministrazione sottocutanea | - | - | - | - | [1] 51 51 💬
|
| 317 | IMMUNOGLOBULINA UMANA NORMALE | - | - | - | - | [4] 14 14, 51, 63, 65 💬
|
| 318 | IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa | - | - | - | - | [1] 14 14 💬
|
| 319 | Immunoglobuline G | - | - | - | - | [1] 14 14 💬
|
| 320 | Immunoglobuline humaine normale | - | - | - | - | [1] 14 14 💬
|
| 321 | Immunoglobulines humaines normales | - | - | - | - | [1] 222 222 💬
|
| 322 | Immunoglobulins | - | - | - | - | [1] 14 14 💬
|
| 323 | Immunoglobulins Intravenous (Human) | - | - | - | - | [1] 65 65 💬
|
| 324 | Immunoglobulins, normal human | - | - | - | - | [1] 65 65 💬
|
| 325 | Immunoglobulins, normal human, for extravascular adm. | - | - | - | - | [1] 14 14 💬
|
| 326 | Immunoglobulins, normal human, for intravascular adm. | - | - | - | - | [2] 14 14, 15 💬
|
| 327 | Immunological diagnosis tests | - | - | - | - | [1] 65 65 💬
|
| 328 | Immunonutrition | - | - | - | - | [2] 96 96, 226 💬
|
| 329 | Immunoscintigraphy with radiolabeled Cimzia®. | - | - | - | - | [1] 46 46 💬
|
| 330 | Immunosporin | - | - | - | - | [1] 46 46 💬
|
| 331 | Immunosuppressant | - | - | - | - | [2] 96 96, 224 💬
|
| 332 | Immunosuppressant other than CYC | - | - | - | - | [1] 49 49 💬
|
| 333 | Immunosuppressants | - | - | - | - | [1] 66 66 💬
|
| 334 | Immunosuppression | - | - | - | - | [1] 240 240 💬
|
| 335 | Immunosuppression Only Conditioning | - | - | - | - | [1] 65 65 💬
|
| 336 | Immunosuppression Only Conditioning -Closed with amendment L | - | - | - | - | [1] 65 65 💬
|
| 337 | IMMUNOSUPPRESSIVE AGENTS | - | - | - | - | [4] 13 13, 50, 96, 223 💬
|
| 338 | Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate) | [3] Azathioprine Azathioprine, Methotrexate, Mycophenolate mofetil | [6] Methotrexate
Methotrexate
,
Azathioprine
,
Mycophenolate mofetil
,
Methotrexate sodium
,
Azathioprine sodium
,
Mycophenolate mofetil hydrochloride
💬
| [4] DHFR DHFR, DHFR2, IMPDH1, IMPDH2 💬
| [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate, Purine metabolism 💬 | [1] 49 49 💬
|
| 339 | Immunosuppressive Regimen | - | - | - | - | [1] 6 6 💬
|
| 340 | Immunosuppressive Therapy (IST) | - | - | - | - | [1] 60 60 💬
|
| 341 | Immunosuppressive treatment | - | - | - | - | [1] 66 66 💬
|
| 342 | Immunosuppressive treatment (eg, rituximab) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 64 64 💬
|
| 343 | Immunosuppressor/TNFalpha | - | - | - | - | [1] 96 96 💬
|
| 344 | Immunotherapy | - | - | - | - | [1] 96 96 💬
|
| 345 | IMNOVID | - | - | - | - | [1] 28 28 💬
|
| 346 | IMNOVID 1 mg | - | - | - | - | [1] 28 28 💬
|
| 347 | Imnovid 1 mg hard capsules | - | - | - | - | [1] 51 51 💬
|
| 348 | IMNOVID 2 mg | - | - | - | - | [1] 28 28 💬
|
| 349 | IMNOVID 4 mg | - | - | - | - | [1] 28 28 💬
|
| 350 | IMO-8400 | - | - | - | - | [1] 50 50 💬
|
| 351 | IMO-8400 Dose Group 1 | - | - | - | - | [1] 50 50 💬
|
| 352 | IMO-8400 Dose Group 2 | - | - | - | - | [1] 50 50 💬
|
| 353 | IMod.Fc, H-Fcv3-N4 | - | - | - | - | [1] 84 84 💬
|
| 354 | Imolope | - | - | - | - | [1] 97 97 💬
|
| 355 | IMP will be labeled as ''PF-04236921 106mg/vial, Clonal SC lyophilized form''. | - | - | - | - | [1] 96 96 💬
|
| 356 | IMP will be labeled as PF-04236921 106mg/vial, Clonal SC lyophilized form | - | - | - | - | [1] 96 96 💬
|
| 357 | Impact-Nutridrink | - | - | - | - | [1] 299 299 💬
|
| 358 | Impedance analysis | - | - | - | - | [1] 162 162 💬
|
| 359 | Implant Procedure | - | - | - | - | [1] 46 46 💬
|
| 360 | Implante de Octreótida | - | - | - | - | [1] 77 77 💬
|
| 361 | Implitapide | [1] Implitapide Implitapide | - | - | - | [1] 79 79 💬
|
| 362 | IMPT-514 | - | - | - | - | [1] 49 49 💬
|
| 363 | IMPT-514 CART Cell Injection | - | - | - | - | [1] 49 49 💬
|
| 364 | Imraldi | - | - | - | - | [2] 96 96, 97 💬
|
| 365 | IMRALDI 40mg | - | - | - | - | [1] 46 46 💬
|
| 366 | Imrecoxib | [1] Imrecoxib Imrecoxib | - | - | - | [1] 271 271 💬
|
| 367 | IMS001 | - | - | - | - | [1] 13 13 💬
|
| 368 | Imsidolimab | [1] Imsidolimab Imsidolimab | [1] Imsidolimab
Imsidolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 37 37 💬
|
| 369 | Imsidolimab high dose | [1] Imsidolimab Imsidolimab | [1] Imsidolimab
Imsidolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 37 37 💬
|
| 370 | Imsidolimab low dose | [1] Imsidolimab Imsidolimab | [1] Imsidolimab
Imsidolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 37 37 💬
|
| 371 | IMU-838 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 372 | IMU-838 (10 mg/day) | - | - | - | - | [1] 13 13 💬
|
| 373 | IMU-838 (30 mg/day) | - | - | - | - | [1] 13 13 💬
|
| 374 | IMU-838 (45 mg/day) | - | - | - | - | [1] 13 13 💬
|
| 375 | IMU-838 tablets | - | - | - | - | [1] 13 13 💬
|
| 376 | IMU-838-RC | - | - | - | - | [1] 13 13 💬
|
| 377 | Imukin | - | - | - | - | [3] 18 18, 58, 228 💬
|
| 378 | IMUKIN - 6 FLACONI 0.5 ML 100 MCG | - | - | - | - | [2] 18 18, 58 💬
|
| 379 | IMUKIN*SC 6F 0,5ML 100MCG | - | - | - | - | [1] 18 18 💬
|
| 380 | Imuran | - | - | - | - | [2] 96 96, 97 💬
|
| 381 | Imurek 25mg Filmtabletten | - | - | - | - | [1] 97 97 💬
|
| 382 | Imurek 50mg Filmtabletten | - | - | - | - | [1] 97 97 💬
|
| 383 | IMUREL | - | - | - | - | [7] 13 13, 44, 45, 46, 54, 96, 97 💬
|
| 384 | IMUREL 25 mg | - | - | - | - | [3] 44 44, 45, 96 💬
|
| 385 | Imvotamab | [1] Imvotamab Imvotamab | [1] Imvotamab
Imvotamab
💬
| [2] CD3E CD3E, MS4A1 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2] 46 46, 49 💬
|
| 386 | IMVT-1401 | - | - | - | - | [2] 11 11, 14 💬
|
| 387 | IMVT-1402 | [1] IMVT-1402 IMVT-1402 | - | - | - | [3] 11 11, 46, 53 💬
|
| 388 | In double-blind phase: treatment with tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 107 107 💬
|
| 389 | In open-label phase: treatment with tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 107 107 💬
|
| 390 | In vitro-treated bone marrow transplantation | - | - | - | - | [1] 60 60 💬
|
| 391 | In vitro-treated peripheral blood stem cell transplantation | - | - | - | - | [2] 60 60, 65 💬
|
| 392 | Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus | - | - | - | - | [1] 53 53 💬
|
| 393 | Inactivated hepatitis A virus | - | - | - | - | [1] 46 46 💬
|
| 394 | Inactivated influenza vaccine (IIV) at baseline | - | - | - | - | [2] 46 46, 97 💬
|
| 395 | Inactivated influenza vaccine at Month 1 | - | - | - | - | [2] 46 46, 97 💬
|
| 396 | Inactivated Trivalent Influenza vaccine | - | - | - | - | [1] 63 63 💬
|
| 397 | Inactive Reminder Capsules | - | - | - | - | [1] 19 19 💬
|
| 398 | Inactive Reminder Product | - | - | - | - | [1] 19 19 💬
|
| 399 | INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI | - | - | - | - | [1] 294 294 💬
|
| 400 | INALOSSIN 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO | - | - | - | - | [1] 294 294 💬
|
| 401 | Inaticabtagene Autoleucel | [1] Inaticabtagene Autoleucel Inaticabtagene Autoleucel | - | - | - | [3] 49 49, 61, 63 💬
|
| 402 | Inaticabtagene autoleucel Injection | [1] Inaticabtagene Autoleucel Inaticabtagene Autoleucel | - | - | - | [3] 49 49, 61, 63 💬
|
| 403 | INBRX-101 | [1] INBRX-101 INBRX-101 | - | - | - | [1] 231 231 💬
|
| 404 | INBRX-101/rhAAT-Fc | [1] INBRX-101 INBRX-101 | - | - | - | [1] 231 231 💬
|
| 405 | INCA000585 | - | - | - | - | [1] 63 63 💬
|
| 406 | IncabotulinumtoxinA | - | - | - | - | [1] 13 13 💬
|
| 407 | INCB000928 | - | - | - | - | [1] 272 272 💬
|
| 408 | INCB000928 fumarate dihydrate | - | - | - | - | [1] 272 272 💬
|
| 409 | INCB000928Pharmaceutical Form: Film-coated tabletCurrent Sponsor code: INCB000928Other descriptive name: INCB000928 fumarate dihydrateConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 25-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use | - | - | - | - | [1] 272 272 💬
|
| 410 | INCB018424 | - | - | - | - | [1] 46 46 💬
|
| 411 | INCB028050 | - | - | - | - | [1] 46 46 💬
|
| 412 | INCB028050 phosphate | - | - | - | - | [1] 46 46 💬
|
| 413 | INCB028050 phosphate salt | - | - | - | - | [1] 46 46 💬
|
| 414 | INCB039110 | - | - | - | - | [3] 51 51, 97, 228 💬
|
| 415 | INCB047986 | - | - | - | - | [1] 46 46 💬
|
| 416 | INCB050465 | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [2] 35 35, 61 💬
|
| 417 | INCB050465 0.3 mg | - | - | - | - | [1] 35 35 💬
|
| 418 | INCB050465 0.3mg | - | - | - | - | [1] 35 35 💬
|
| 419 | INCB050465 1 mg | - | - | - | - | [1] 61 61 💬
|
| 420 | INCB050465 1.0 mg | - | - | - | - | [1] 35 35 💬
|
| 421 | INCB050465 1.0mg | - | - | - | - | [1] 35 35 💬
|
| 422 | INCB050465 2.5 mg | - | - | - | - | [1] 61 61 💬
|
| 423 | INCB050465 2.5mg | - | - | - | - | [1] 35 35 💬
|
| 424 | INCB050465 HYDROCHLORIDE | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [2] 35 35, 61 💬
|
| 425 | INCLISIRAN | [1] Inclisiran Inclisiran | [2] Inclisiran
Inclisiran
,
Inclisiran sodium
💬
| [1] PCSK9 PCSK9 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 426 | Inclisiran (Leqvio®) 300mg | [1] Inclisiran Inclisiran | [2] Inclisiran
Inclisiran
,
Inclisiran sodium
💬
| [1] PCSK9 PCSK9 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 427 | Inclisiran for Injection | [1] Inclisiran Inclisiran | [2] Inclisiran
Inclisiran
,
Inclisiran sodium
💬
| [1] PCSK9 PCSK9 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 428 | Inclisiran Sodium | [1] Inclisiran Inclisiran | [2] Inclisiran
Inclisiran
,
Inclisiran sodium
💬
| [1] PCSK9 PCSK9 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 429 | Inclisiran Sodium for injection | [1] Inclisiran Inclisiran | [2] Inclisiran
Inclisiran
,
Inclisiran sodium
💬
| [1] PCSK9 PCSK9 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 430 | Incobotulinum Toxin A | - | - | - | - | [3] 2 2, 6, 13 💬
|
| 431 | IncobotulinumtoxinA | - | - | - | - | [1] 6 6 💬
|
| 432 | IncobotulinumtoxinA (100 Units) | - | - | - | - | [1] 6 6 💬
|
| 433 | IncobotulinumtoxinA (75 Units) | - | - | - | - | [1] 6 6 💬
|
| 434 | Increased exercise intensity | - | - | - | - | [1] 113 113 💬
|
| 435 | Increased Varenicline Dosing (1mg TID) | [1] Varenicline Varenicline | [2] Varenicline tartrate
Varenicline tartrate
,
Varenicline
💬
| [2] CHRNA4 CHRNA4, CHRNB2 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | [1] 298 298 💬
|
| 436 | Increlex | - | - | - | - | [2] 65 65, 96 💬
|
| 437 | Increlex 10mg/ml solution for injection | - | - | - | - | [1] 96 96 💬
|
| 438 | INCRELEX*SC 1FL 4ML 10MG/ML | - | - | - | - | [1] 299 299 💬
|
| 439 | IND 127861 | - | - | - | - | [2] 51 51, 53 💬
|
| 440 | Indapamide | [1] Indapamide Indapamide | [1] Indapamide
Indapamide
💬
| [1] SLC12A3 SLC12A3 💬
| [1] Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action 💬 | [2] 13 13, 235 💬
|
| 441 | Indapamide 1.5 MG SR | [1] Indapamide Indapamide | [1] Indapamide
Indapamide
💬
| [1] SLC12A3 SLC12A3 💬
| [1] Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 442 | Indapamide Pill | [1] Indapamide Indapamide | [1] Indapamide
Indapamide
💬
| [1] SLC12A3 SLC12A3 💬
| [1] Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action 💬 | [1] 13 13 💬
|
| 443 | Indigo | [1] Indigo Indigo | - | - | - | [3] 97 97, 289, 300 💬
|
| 444 | Indigo-carmine 0.2% using a spray catheter | [1] Indigo Indigo | - | - | - | [1] 97 97 💬
|
| 445 | Indinavir | [1] Indinavir Indinavir | [3] Indinavir sulfate
Indinavir sulfate
,
Indinavir sulfate ethanolate
,
Indinavir
💬
| - | - | [1] 265 265 💬
|
| 446 | Indirect Calorimetry | - | - | - | - | [1] 299 299 💬
|
| 447 | Indium | [1] Indium Indium | - | - | - | [3] 28 28, 84, 299 💬
|
| 448 | Indium 111-radiolabelled anti-CD66 | [1] Indium Indium | - | - | - | [1] 28 28 💬
|
| 449 | Indium-111 Pentreotide | [1] Indium Indium | - | - | - | [1] 84 84 💬
|
| 450 | Indium-DTPA | [1] Indium Indium | - | - | - | [1] 299 299 💬
|
| 451 | Indium 111 labelled Anti-CD66 | [1] Indium Indium | - | - | - | [1] 28 28 💬
|
| 452 | Individualized dose of rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 453 | Indobufen | [1] Indobufen Indobufen | [1] Indobufen
Indobufen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 222 222 💬
|
| 454 | Indocyanine green | [2] Indocyanine green Indocyanine green, Indocyanine green acid form | [1] Indocyanine green
Indocyanine green
💬
| - | - | [9] 22 22, 41, 46, 51, 96, 235, 278, 291, 296 💬
|
| 455 | Indocyanine Green (ICG) | [2] Indocyanine green Indocyanine green, Indocyanine green acid form | [1] Indocyanine green
Indocyanine green
💬
| - | - | [1] 296 296 💬
|
| 456 | Indocyanine Green near infrared fluorescence imaging | [2] Indocyanine green Indocyanine green, Indocyanine green acid form | [1] Indocyanine green
Indocyanine green
💬
| - | - | [1] 235 235 💬
|
| 457 | Indocyanine green(ICG) | [2] Indocyanine green Indocyanine green, Indocyanine green acid form | [1] Indocyanine green
Indocyanine green
💬
| - | - | [1] 46 46 💬
|
| 458 | Indocyanine green-guided partial resection and sclerotherapy | [2] Indocyanine green Indocyanine green, Indocyanine green acid form | [1] Indocyanine green
Indocyanine green
💬
| - | - | [1] 278 278 💬
|
| 459 | Indole | [1] Indole Indole | - | - | - | [2] 13 13, 51 💬
|
| 460 | Indole-3-propionic acid (IPA) | [1] Indole Indole | - | - | - | [1] 13 13 💬
|
| 461 | INDOMETACIN | - | - | - | - | [1] 225 225 💬
|
| 462 | Indomethacin | [1] Indomethacin Indomethacin | [2] Indomethacin
Indomethacin
,
Indomethacin sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [3] 225 225, 271, 298 💬
|
| 463 | Induction- PF-06480605 150 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 464 | Induction- PF-06480605 450 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 465 | Induction- PF-06480605 50 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 466 | INDUSIL*OS GTT FL 30MG+FL 15ML | - | - | - | - | [1] 299 299 💬
|
| 467 | INEBILIZUMAB | [1] Inebilizumab Inebilizumab | [1] Inebilizumab
Inebilizumab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [8] 11 11, 13, 46, 49, 51, 53, 95, 300 💬
|
| 468 | Inebilizumab + Rapid Steroid Tapering group | [1] Inebilizumab Inebilizumab | [1] Inebilizumab
Inebilizumab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [1] 13 13 💬
|
| 469 | Inebilizumab + Standard Steroid Tapering group | [1] Inebilizumab Inebilizumab | [1] Inebilizumab
Inebilizumab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [1] 13 13 💬
|
| 470 | INF beta-1a | - | - | - | - | [1] 13 13 💬
|
| 471 | Infacort | - | - | - | - | [1] 81 81 💬
|
| 472 | Infacort® | - | - | - | - | [1] 81 81 💬
|
| 473 | Infection prophylaxis and management | - | - | - | - | [2] 28 28, 60 💬
|
| 474 | Infectogenta | - | - | - | - | [1] 36 36 💬
|
| 475 | INFIGRATINIB | [1] Infigratinib Infigratinib | [2] Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬
| [22] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 💬
|
| 476 | Infigratinib 0.016 mg/kg | [1] Infigratinib Infigratinib | [2] Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬
| [22] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 💬
|
| 477 | Infigratinib 0.032 mg/kg | [1] Infigratinib Infigratinib | [2] Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬
| [22] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 💬
|
| 478 | Infigratinib 0.064 mg/kg | [1] Infigratinib Infigratinib | [2] Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬
| [22] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 💬
|
| 479 | Infigratinib 0.128 mg/kg | [1] Infigratinib Infigratinib | [2] Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬
| [22] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 💬
|
| 480 | Infigratinib 0.25 mg/kg | [1] Infigratinib Infigratinib | [2] Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬
| [22] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 💬
|
| 481 | Infigratinib 0.25 mg/kg/day | [1] Infigratinib Infigratinib | [2] Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬
| [22] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 💬
|
| 482 | Infigratinib is provided as a single dose of minitablets for oral administration | [1] Infigratinib Infigratinib | [2] Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬
| [22] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 💬
|
| 483 | Infigratinib is provided as sprinkle capsules for daily oral administration | [1] Infigratinib Infigratinib | [2] Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬
| [22] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 💬
|
| 484 | Infigratinib phosphate | [1] Infigratinib Infigratinib | [2] Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬
| [22] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 💬
|
| 485 | Inflammatory profile | - | - | - | - | [1] 113 113 💬
|
| 486 | Inflectra | - | - | - | - | [4] 46 46, 56, 96, 97 💬
|
| 487 | Inflectra (Infliximab) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 95 95 💬
|
| 488 | INFLECTRA - 100 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 1 FLACONCINO | - | - | - | - | [1] 56 56 💬
|
| 489 | Inflectra 100 mg | - | - | - | - | [1] 97 97 💬
|
| 490 | Inflectra 100 mg powder for concentrate for solution for infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 491 | Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
|
| 492 | Infliximab (BCD-055) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 493 | Infliximab (IFX alone) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 494 | Infliximab (IFX) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 495 | Infliximab (INF) + MTX, DB | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 496 | Infliximab (Remicade) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 271 💬
|
| 497 | Infliximab (Remicade): 100 mg of lyophilized infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 498 | Infliximab + methotrexate (MTX) | [2] Infliximab Infliximab, Methotrexate | [3] Methotrexate
Methotrexate
,
Methotrexate sodium
,
Infliximab
💬
| [3] DHFR DHFR, DHFR2, TNF 💬
| [69] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 499 | Infliximab 10 mg/kg | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 500 | Infliximab 20 mg/kg | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 501 | Infliximab 3 mg/kg | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 502 | Infliximab 5 mg/kg | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 503 | Infliximab 5 mg/kg body weight infused over 2 hours | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 504 | Infliximab 5 mg/kg every 6 weeks | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 505 | Infliximab 7 mg/kg every 8 weeks | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 506 | Infliximab [infliximab biosimilar 3] | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 37 37, 46, 96, 97 💬
|
| 507 | Infliximab Adalimumab y Golimumab | [3] Adalimumab Adalimumab, Golimumab, Infliximab | [3] Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 508 | Infliximab and adalimumab | [2] Adalimumab Adalimumab, Infliximab | [2] Adalimumab
Adalimumab
,
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 509 | Infliximab and azathioprine combination at week 0 | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 510 | Infliximab and azathioprine combination at week 14 | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 511 | Infliximab and immunosuppressives | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 512 | Infliximab and MTX | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 513 | Infliximab at weeks 0 and 8 | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 514 | Infliximab at weeks 0,2, and 6 | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 515 | Infliximab at weeks 0,4, and 8 | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 516 | Infliximab biosimilar | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 271 💬
|
| 517 | Infliximab combined with azathioprine therapy | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 518 | Infliximab Control | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 519 | Infliximab Dose Intensification | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 520 | Infliximab group | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 521 | Infliximab Increased Dose | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 522 | Infliximab Increased Frequency | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 523 | Infliximab infusion | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 524 | Infliximab monotherapy | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 525 | Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib | [6] Adalimumab Adalimumab, Golimumab, Infliximab, Tofacitinib, Ustekinumab, Vedolizumab | [7] Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
,
Vedolizumab
,
Ustekinumab
,
Tofacitinib citrate
,
Tofacitinib
💬
| [10] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, JAK1, JAK2, JAK3, TNF, TYK2 💬
| [97] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 526 | Infliximab plus methotrexate | [2] Infliximab Infliximab, Methotrexate | [3] Methotrexate
Methotrexate
,
Methotrexate sodium
,
Infliximab
💬
| [3] DHFR DHFR, DHFR2, TNF 💬
| [69] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 💬
|
| 527 | Infliximab precision dosing | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 528 | Infliximab subcutaneous | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 529 | Infliximab therapeutic drug monitoring | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 530 | Infliximab Treatment | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 531 | Infliximab with azathioprine (IIFX + AZA) | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 532 | Infliximab+azathioprine | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 533 | Infliximab, adalimumab, certolizumab pegol | [3] Adalimumab Adalimumab, Certolizumab pegol, Infliximab | [3] Adalimumab
Adalimumab
,
Infliximab
,
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 534 | Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab | [5] Adalimumab Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab | [5] Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
,
Vedolizumab
,
Ustekinumab
💬
| [6] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 535 | Infliximab, azathioprine | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 536 | Infliximab, etanercept | [2] Etanercept Etanercept, Infliximab | [2] Etanercept
Etanercept
,
Infliximab
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 537 | Infliximab, etanercept, adalimumab | [3] Adalimumab Adalimumab, Etanercept, Infliximab | [3] Etanercept
Etanercept
,
Adalimumab
,
Infliximab
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 538 | Infliximab, methylprednisolone, methotrexate | [3] Infliximab Infliximab, Methotrexate, Methylprednisolone | [5] Methotrexate
Methotrexate
,
Methylprednisolone
,
Methylprednisolone acetate
,
Methotrexate sodium
,
Infliximab
💬
| [4] DHFR DHFR, DHFR2, NR3C1, TNF 💬
| [70] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 539 | Infliximab-Biosimilar | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 540 | Infliximab-Dyyb | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 541 | Infliximab-EU | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 542 | Infliximab-Innovator | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 543 | Infliximab-Pfizer | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 544 | Infliximab: Adalimumab | [2] Adalimumab Adalimumab, Infliximab | [2] Adalimumab
Adalimumab
,
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 271 💬
|
| 545 | Inflow occlusion with perforation of septation and sclerotherapy | - | - | - | - | [1] 278 278 💬
|
| 546 | Influenz virus surface antigens | - | - | - | - | [1] 49 49 💬
|
| 547 | Influenza vaccination | - | - | - | - | [2] 97 97, 299 💬
|
| 548 | Influenza vaccine | - | - | - | - | [6] 11 11, 13, 46, 51, 84, 97 💬
|
| 549 | INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED) | - | - | - | - | [1] 49 49 💬
|
| 550 | Influenza vaccine, Immune function | - | - | - | - | [1] 107 107 💬
|
| 551 | Influvac | - | - | - | - | [3] 46 46, 49, 50 💬
|
| 552 | Infracyanine | - | - | - | - | [1] 235 235 💬
|
| 553 | Infudopa i.v. | - | - | - | - | [1] 6 6 💬
|
| 554 | Infudopa s.c. | - | - | - | - | [1] 6 6 💬
|
| 555 | Infusion of ADR-001 (Mesenchymal stem cell) | - | - | - | - | [2] 66 66, 223 💬
|
| 556 | Infusion of autologous mononuclear bone marrow cells | - | - | - | - | [1] 57 57 💬
|
| 557 | Infusion of Saline | - | - | - | - | [1] 97 97 💬
|
| 558 | Infusion Pump: CADD-Legacy® 1400 Pump | - | - | - | - | [1] 6 6 💬
|
| 559 | Infusion without ALD518' | - | - | - | - | [1] 46 46 💬
|
| 560 | Infusions of young plasma | - | - | - | - | [1] 6 6 💬
|
| 561 | Inhalation | - | - | - | - | [1] 228 228 💬
|
| 562 | Inhaled 7% hypertonic saline (HS) | - | - | - | - | [1] 299 299 💬
|
| 563 | Inhaled AR-501 | - | - | - | - | [1] 299 299 💬
|
| 564 | Inhaled BMD003(CFTR mRNA) | - | - | - | - | [1] 299 299 💬
|
| 565 | Inhaled Cannabis | - | - | - | - | [1] 13 13 💬
|
| 566 | Inhaled carbon monoxide | [1] Carbon monoxide Carbon monoxide | [1] Carbon monoxide
Carbon monoxide
💬
| - | - | [1] 85 85 💬
|
| 567 | Inhaled Dry Powder Mannitol | [1] Mannitol Mannitol | [1] Mannitol
Mannitol
💬
| - | - | [1] 299 299 💬
|
| 568 | Inhaled dry powder treprostinil (LIQ861) | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 569 | Inhaled hypertonic saline (7%) | - | - | - | - | [1] 299 299 💬
|
| 570 | Inhaled Iloprost (5 µg) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 571 | Inhaled iloprost (Ventavis, BAYQ6256) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 572 | Inhaled Mannitol | [1] Mannitol Mannitol | [1] Mannitol
Mannitol
💬
| - | - | [1] 299 299 💬
|
| 573 | Inhaled Nitric Oxide | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [3] 85 85, 86, 294 💬
|
| 574 | Inhaled nitric oxide & INOpulse delivery | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 86 86 💬
|
| 575 | Inhaled Nitric Oxide (iNO) use | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 294 294 💬
|
| 576 | Inhaled Nitric Oxide - 30 mcg/kg IBW/hr | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 85 85 💬
|
| 577 | Inhaled Nitric Oxide 5,10,15 mcg/Kg IBW/hr | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 85 85 💬
|
| 578 | Inhaled nitric oxide 75 mcg/kg IBW/hr | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [2] 85 85, 86 💬
|
| 579 | Inhaled NO with pulsed delivery | - | - | - | - | [1] 86 86 💬
|
| 580 | Inhaled prostacyclin | - | - | - | - | [1] 86 86 💬
|
| 581 | Inhaled Reduced Glutathione | [1] Glutathione Glutathione | [1] Glutathione
Glutathione
💬
| - | - | [1] 299 299 💬
|
| 582 | Inhaled SNSP113 | [1] SNSP113 SNSP113 | - | - | - | [1] 299 299 💬
|
| 583 | Inhaled Sodium Pyruvate | [1] Pyruvic acid Pyruvic acid | - | - | - | [1] 299 299 💬
|
| 584 | Inhaled TD139 | - | - | - | - | [1] 85 85 💬
|
| 585 | Inhaled tobramycin | [1] Tobramycin Tobramycin | [2] Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | [1] 299 299 💬
|
| 586 | Inhaled Treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [3] 84 84, 85, 86 💬
|
| 587 | Inhaled Vancomycin | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [1] 299 299 💬
|
| 588 | Inhaled VR040 | - | - | - | - | [1] 6 6 💬
|
| 589 | Inhaled/swallowed budesonide | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬
|
| 590 | Inhaler | - | - | - | - | [1] 299 299 💬
|
| 591 | Inhibace/Cozaar | - | - | - | - | [2] 66 66, 223 💬
|
| 592 | INHIBIDOR DE LA ESTERASA C1 COMPLEMENTO | - | - | - | - | [1] 65 65 💬
|
| 593 | Initiation of CFTR Modulator | - | - | - | - | [1] 299 299 💬
|
| 594 | Inj. Methotrexate 25mg/week | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 46 46 💬
|
| 595 | Injectable MS DMT | - | - | - | - | [1] 13 13 💬
|
| 596 | Injectable Somatostatin Analogs (octreotide or lanreotide) | [3] Lanreotide Lanreotide, Octreotide, Somatostatin | [7] Octreotide
Octreotide
,
Octreotide acetate
,
Lanreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Somatostatin
,
Octreotide hydrochloride
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 597 | Injectafer | - | - | - | - | [1] 97 97 💬
|
| 598 | Injectafer /ferinject. | - | - | - | - | [1] 97 97 💬
|
| 599 | Injectafer 50 mg ijzer / ml oplossing voor injectie/infusie | - | - | - | - | [1] 97 97 💬
|
| 600 | Injection | - | - | - | - | [2] 6 6, 301 💬
|
| 601 | Injection needle | - | - | - | - | [1] 302 302 💬
|
| 602 | Injection of 68Ga-NI-FAPI | - | - | - | - | [1] 58 58 💬
|
| 603 | INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS | - | - | - | - | [1] 51 51 💬
|
| 604 | Injection of apomorphine | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 605 | Injection of autologous bone marrow derived mesenchymal stem cells | - | - | - | - | [1] 13 13 💬
|
| 606 | Injection of autologous stromal vascular fraction | - | - | - | - | [1] 51 51 💬
|
| 607 | Injection of cell free media | - | - | - | - | [1] 13 13 💬
|
| 608 | Injection of CNK-UT009 | - | - | - | - | [2] 96 96, 97 💬
|
| 609 | Injection of iron | - | - | - | - | [1] 96 96 💬
|
| 610 | Injection of MSC303 | - | - | - | - | [1] 223 223 💬
|
| 611 | Injection of normal saline | - | - | - | - | [1] 6 6 💬
|
| 612 | Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01) | [1] Iodine Iodine | [1] Iodine
Iodine
💬
| - | - | [1] 28 28 💬
|
| 613 | Injection of salivary glands | - | - | - | - | [1] 2 2 💬
|
| 614 | Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa | - | - | - | - | [1] 90 90 💬
|
| 615 | Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa | - | - | - | - | [1] 90 90 💬
|
| 616 | Injection of thawed SVF | - | - | - | - | [1] 96 96 💬
|
| 617 | Injection of Umbilical cord derived MSCs | - | - | - | - | [1] 6 6 💬
|
| 618 | Injection Sclerotherapy | - | - | - | - | [1] 278 278 💬
|
| 619 | Injection, Etanercept, 25 Mg (Code May Be Used for Medicare When Drug Administered Under the Direct Supervision of A Physician, Not for Use When Drug is Self Administered) | [1] Etanercept Etanercept | [1] Etanercept
Etanercept
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 💬
|
| 620 | Injections on posterior bladder wall excluding the trigone | - | - | - | - | [1] 226 226 💬
|
| 621 | Injections upper aspect of trigone of urinary bladder | - | - | - | - | [1] 226 226 💬
|
| 622 | INM-755 | - | - | - | - | [1] 36 36 💬
|
| 623 | INM-755 (cannabinol) cream | [1] Cannabinol Cannabinol | - | - | - | [1] 36 36 💬
|
| 624 | INN - FILGOTINIB | [1] Filgotinib Filgotinib | [2] Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 💬
|
| 625 | INN COLECALCIFEROL | - | - | - | - | [1] 13 13 💬
|
| 626 | INN Not available | - | - | - | - | [2] 19 19, 46 💬
|
| 627 | INN not available at this time | - | - | - | - | [1] 6 6 💬
|
| 628 | INN not available yet | - | - | - | - | [1] 222 222 💬
|
| 629 | INN Not yet proposed | - | - | - | - | [1] 193 193 💬
|
| 630 | INN Parathyroid Hormone (1-84) human | [1] Parathyroid hormone Parathyroid hormone | [1] Parathyroid hormone
Parathyroid hormone
💬
| [2] PTH1R PTH1R, PTH2R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 631 | INN-Tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 266 266 💬
|
| 632 | INN: aceneuramic acid | [1] Aceneuramic acid Aceneuramic acid | [1] Aceneuramic acid
Aceneuramic acid
💬
| - | - | [1] 30 30 💬
|
| 633 | INN: kryzotynib (crizotinib) | [1] Crizotinib Crizotinib | [1] Crizotinib
Crizotinib
💬
| [1] ALK ALK 💬
| [3] Non-small cell lung cancer Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬 | [1] 34 34 💬
|
| 634 | Innohep | - | - | - | - | [1] 327 327 💬
|
| 635 | Innovator infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 636 | INNOZIDE | - | - | - | - | [1] 19 19 💬
|
| 637 | INO | - | - | - | - | [2] 85 85, 86 💬
|
| 638 | INOmax 400ppm mol/mol inhalation gas | - | - | - | - | [2] 85 85, 299 💬
|
| 639 | INOmax 800ppm mol/mol inhalatiegas | - | - | - | - | [1] 294 294 💬
|
| 640 | Inoserten | - | - | - | - | [1] 28 28 💬
|
| 641 | Inosine | [1] Inosine Inosine | [1] Inosine
Inosine
💬
| - | - | [5] 2 2, 6, 13, 17, 122 💬
|
| 642 | Inositol | [1] Inositol Inositol | [1] Inositol
Inositol
💬
| - | - | [3] 96 96, 97, 118 💬
|
| 643 | INOTERSEN | [1] Inotersen Inotersen | [2] Inotersen
Inotersen
,
Inotersen sodium
💬
| [1] TTR TTR 💬
| [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 💬
|
| 644 | Inovelon | - | - | - | - | [1] 144 144 💬
|
| 645 | INS-GSH | - | - | - | - | [1] 6 6 💬
|
| 646 | INS018_055 | - | - | - | - | [1] 85 85 💬
|
| 647 | INS1007 | - | - | - | - | [2] 44 44, 299 💬
|
| 648 | INS1009 | - | - | - | - | [1] 86 86 💬
|
| 649 | Insertable cardiac monitor | - | - | - | - | [2] 58 58, 217 💬
|
| 650 | Instillation of fibrin glue | [1] Fibrin Fibrin | - | - | - | [1] 96 96 💬
|
| 651 | Insulin | - | - | - | - | [6] 6 6, 13, 46, 75, 77, 299 💬
|
| 652 | Insulin Asparte | - | - | - | - | [1] 299 299 💬
|
| 653 | Insulin detemir | [1] Insulin detemir Insulin detemir | [1] Insulin detemir
Insulin detemir
💬
| [1] INSR INSR 💬
| [23] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Hormone signaling, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 299 299 💬
|
| 654 | Insulin detemir [rDNA origin] injection | [1] Insulin detemir Insulin detemir | [1] Insulin detemir
Insulin detemir
💬
| [1] INSR INSR 💬
| [23] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Hormone signaling, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 299 299 💬
|
| 655 | Insulin glargine | [1] Insulin glargine Insulin glargine | [1] Insulin glargine
Insulin glargine
💬
| [1] INSR INSR 💬
| [23] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Hormone signaling, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [2] 35 35, 299 💬
|
| 656 | Insulin like growth factor, type 1 | - | - | - | - | [1] 2 2 💬
|
| 657 | Insulin lispro | [1] Insulin lispro Insulin lispro | [1] Insulin lispro
Insulin lispro
💬
| [1] INSR INSR 💬
| [23] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Hormone signaling, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 53 53 💬
|
| 658 | Insulin Pump | - | - | - | - | [1] 299 299 💬
|
| 659 | Insulin pump (Medtronic) | - | - | - | - | [1] 81 81 💬
|
| 660 | Insuline humaine recombinante | - | - | - | - | [1] 299 299 💬
|
| 661 | INT-210 Capsule | - | - | - | - | [1] 97 97 💬
|
| 662 | INT-747 | - | - | - | - | [1] 93 93 💬
|
| 663 | INT-747, OCA | - | - | - | - | [2] 93 93, 94 💬
|
| 664 | INT131 | - | - | - | - | [1] 13 13 💬
|
| 665 | Inteferone Beta-1A | - | - | - | - | [1] 13 13 💬
|
| 666 | Integra Titan Modular Shoulder System 2.5 | - | - | - | - | [1] 46 46 💬
|
| 667 | Integra TITAN™ Total Shoulder Generation 1.0 | - | - | - | - | [1] 46 46 💬
|
| 668 | Integrated Dual-task EMG Biofeedback Training (EMG-BF) | - | - | - | - | [1] 13 13 💬
|
| 669 | Integrated Traditional Chinese and Western Medicine | - | - | - | - | [1] 46 46 💬
|
| 670 | Integrative Medicine | - | - | - | - | [1] 46 46 💬
|
| 671 | INTELENCE | - | - | - | - | [1] 18 18 💬
|
| 672 | INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE | - | - | - | - | [1] 18 18 💬
|
| 673 | Intensified intravenous omeprazole therapy (loading dose 80 mg IV, then 40 mg IV twice daily at 6:00 AM and 6:00 PM) | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 97 97 💬
|
| 674 | Interferential current | - | - | - | - | [1] 226 226 💬
|
| 675 | Interferon | - | - | - | - | [1] 226 226 💬
|
| 676 | Interferon alfa | [1] Interferon alfa Interferon alfa | [1] Interferon alfa
Interferon alfa
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [5] 25 25, 26, 28, 56, 96 💬
|
| 677 | Interferon Alfa-2A | [2] Interferon alfa Interferon alfa, Interferon alfa-2a | [2] Interferon alfa-2a
Interferon alfa-2a
,
Interferon alfa
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 56 56 💬
|
| 678 | Interferon alfa-2b | [2] Interferon alfa Interferon alfa, Interferon alfa-2b | [2] Interferon alfa-2b
Interferon alfa-2b
,
Interferon alfa
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2] 25 25, 26 💬
|
| 679 | Interferon alpha oral lozenge | - | - | - | - | [1] 85 85 💬
|
| 680 | Interferon Beta | - | - | - | - | [2] 13 13, 20 💬
|
| 681 | INTERFERON BETA - 1A | - | - | - | - | [1] 13 13 💬
|
| 682 | Interferon beta - 1a (IFN) | - | - | - | - | [1] 13 13 💬
|
| 683 | Interferon beta -1b | [1] Human interferon beta Human interferon beta | [1] Interferon beta
Interferon beta
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 684 | Interferon Beta 1 | - | - | - | - | [1] 13 13 💬
|
| 685 | Interferon Beta 1-A | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 686 | Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046) | - | - | - | - | [1] 13 13 💬
|
| 687 | Interferon Beta 1a | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 688 | Interferon beta 1a 30 ug IM once weekly | - | - | - | - | [1] 13 13 💬
|
| 689 | Interferon Beta 1a pegilado | - | - | - | - | [1] 13 13 💬
|
| 690 | Interferon beta 1a, oral doxycycline | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 13 13 💬
|
| 691 | Interferon beta 1B | - | - | - | - | [1] 13 13 💬
|
| 692 | Interferon beta 1b (Betaseron, BAY86-5046) | - | - | - | - | [1] 13 13 💬
|
| 693 | Interferon Beta Therapy | - | - | - | - | [1] 13 13 💬
|
| 694 | Interferon beta treatment to add-on atorvastatin treatment | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬
|
| 695 | Interferon beta type 1a | - | - | - | - | [1] 13 13 💬
|
| 696 | Interferon beta-1 a | - | - | - | - | [1] 13 13 💬
|
| 697 | INTERFERON BETA-1A | [2] Human interferon beta Human interferon beta, Interferon beta-1a | [2] Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [5] 13 13, 14, 26, 96, 97 💬
|
| 698 | Interferon beta-1a (Avonex) | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 699 | INTERFERON BETA-1A (Avonex®) | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 700 | Interferon beta-1a (current approved manufacturing process invloving FBS) | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 701 | Interferon beta-1a (new process, manufactured without FBS) | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 702 | Interferon beta-1a (Rebif) | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 703 | Interferon beta-1a (Rebif®) alone | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 704 | Interferon beta-1a 30 µg | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 705 | Interferon beta-1a FBS-free/HSA free, RNF | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 706 | Interferon beta-1a FBS-free/HSA-free | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 707 | Interferon beta-1a FBS-free/HSA-free, RNF | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 708 | Interferon beta-1a HSA+ biosimilar | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 709 | Interferon beta-1a HSA-free biosimilar | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 710 | Interferon beta-1a original | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 711 | Interferon Beta-1A Prefilled Syringe | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 712 | INTERFERON BETA-1B | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 713 | Interferon beta-1b (Betaferon, BAY 86-5046) | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 714 | Interferon beta-1b (Betaferon, BAY86-5046) | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 715 | Interferon beta-1b (Betaferon/Betaseron, BAY86-5046) | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 716 | Interferon beta-1b (Betaferon®, BAY 86-5046) | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 717 | Interferon beta-1b (Betaseron, BAY86-5046) | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 718 | Interferon beta-1b (Betaseron, Betaferon, BAY86-5046) | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 719 | Interferon beta-1b (PF530, Betaferon) | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 720 | Interferon beta-1b and Tacrolimus | [2] Interferon beta-1b Interferon beta-1b, Tacrolimus | [3] Tacrolimus
Tacrolimus
,
Interferon beta-1b
,
Tacrolimus
💬
| [7] IFNAR1 IFNAR1, IFNAR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [48] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 721 | Interferon beta-1b group | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 722 | Interferon beta-1b, (Betaseron BAY86-5046) | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 723 | Interferon beta-1b, FRP about 6 weeks after randomization | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 724 | Interferon beta-1b, FRP within 15 days after randomization | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 725 | Interferon beta-1b/Atorvastatin group | [2] Atorvastatin Atorvastatin, Interferon beta-1b | [3] Interferon beta-1b
Interferon beta-1b
,
Atorvastatin calcium
,
Atorvastatin
💬
| [3] HMGCR HMGCR, IFNAR1, IFNAR2 💬
| [21] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Terpenoid backbone biosynthesis, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 726 | INTERFERON BETA1A | - | - | - | - | [1] 13 13 💬
|
| 727 | Interferon Gamma | [1] Interferon Gamma Interferon Gamma | - | - | - | [9] 18 18, 65, 85, 96, 107, 228, 299, 301, 326 💬
|
| 728 | Interferon gamma 1b | [1] Interferon Gamma Interferon Gamma | - | - | - | [1] 228 228 💬
|
| 729 | INTERFERON GAMMA-1B | [2] Interferon Gamma Interferon Gamma, Interferon gamma-1b | [1] Interferon gamma-1b
Interferon gamma-1b
💬
| [2] IFNGR1 IFNGR1, IFNGR2 💬
| [18] Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | [7] 18 18, 65, 85, 228, 299, 301, 326 💬
|
| 730 | Interferon gamma-1b (Actimmune) | [2] Interferon Gamma Interferon Gamma, Interferon gamma-1b | [1] Interferon gamma-1b
Interferon gamma-1b
💬
| [2] IFNGR1 IFNGR1, IFNGR2 💬
| [18] Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | [1] 85 85 💬
|
| 731 | Interferon or glatiramer acetate | [2] Acetate Acetate, Glatiramer | [1] Glatiramer acetate
Glatiramer acetate
💬
| [20] HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
| 732 | Interferon ß-1a | - | - | - | - | [1] 13 13 💬
|
| 733 | Interferon ß-1a 30 µg | - | - | - | - | [1] 13 13 💬
|
| 734 | Interferon ß-1b | - | - | - | - | [1] 13 13 💬
|
| 735 | Interferon-1beta (Betaseron, BAY86-5046) | - | - | - | - | [1] 13 13 💬
|
| 736 | Interferon-alpha | - | - | - | - | [1] 331 331 💬
|
| 737 | Interferon-alpha lozenges | - | - | - | - | [1] 85 85 💬
|
| 738 | Interferon-alpha2a | - | - | - | - | [1] 56 56 💬
|
| 739 | Interferon-Beta | - | - | - | - | [1] 13 13 💬
|
| 740 | Interferon-beta (IFN-beta) | - | - | - | - | [1] 13 13 💬
|
| 741 | Interferon-beta 1a | - | - | - | - | [1] 13 13 💬
|
| 742 | Interferon-beta 1a FBS-free/HSA free, RNF | - | - | - | - | [1] 13 13 💬
|
| 743 | Interferon-beta 1a FBS-free/HSA-free, RNF | - | - | - | - | [1] 13 13 💬
|
| 744 | Interferon-beta 1b | - | - | - | - | [1] 13 13 💬
|
| 745 | Interferon-beta 1b (Betaseron) | - | - | - | - | [1] 13 13 💬
|
| 746 | Interferon-beta [IFN-beta] | - | - | - | - | [1] 13 13 💬
|
| 747 | Interferon-beta and human leukocyte Interferon-a | - | - | - | - | [1] 13 13 💬
|
| 748 | Interferon-beta-1 | - | - | - | - | [1] 13 13 💬
|
| 749 | Interferon-beta-1a | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 750 | Interferon-beta-1a (Avonex) plus methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 751 | Interferon-beta-1a FBS-free/HSA free, RNF | - | - | - | - | [1] 13 13 💬
|
| 752 | Interferon-beta-1a FBS-free/HSA-free | - | - | - | - | [1] 13 13 💬
|
| 753 | Interferon-beta-1a, 44 microgram | - | - | - | - | [1] 97 97 💬
|
| 754 | Interferon-beta-1a, 66 microgram | - | - | - | - | [1] 97 97 💬
|
| 755 | Interferon-beta-1b | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 756 | Interferon-beta-1b (BETASERON, BAY 86-5046) | - | - | - | - | [1] 13 13 💬
|
| 757 | Interferon-beta1 | - | - | - | - | [1] 13 13 💬
|
| 758 | Interferon-gamma | - | - | - | - | [1] 65 65 💬
|
| 759 | Interferon-gamma 1b | - | - | - | - | [1] 85 85 💬
|
| 760 | Interferon-ß | - | - | - | - | [1] 13 13 💬
|
| 761 | Interferon-ß [IFN-ß] | - | - | - | - | [1] 13 13 💬
|
| 762 | Interferon-ß-1 | - | - | - | - | [1] 13 13 💬
|
| 763 | Interferon-ß-1a | - | - | - | - | [1] 13 13 💬
|
| 764 | Interferon-ß-1b | - | - | - | - | [1] 13 13 💬
|
| 765 | Interferone | - | - | - | - | [1] 13 13 💬
|
| 766 | Interferone beta 1a | - | - | - | - | [1] 13 13 💬
|
| 767 | INTERFERONE BETA 1B | - | - | - | - | [1] 13 13 💬
|
| 768 | Interferone beta-1a | - | - | - | - | [1] 13 13 💬
|
| 769 | Interferone Beta-1B | - | - | - | - | [1] 13 13 💬
|
| 770 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | [12] Acetate Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, Ofatumumab, Ponesimod, Rituximab, Teriflunomide | [13] Cladribine
Cladribine
,
Alemtuzumab
,
Rituximab
,
Dimethyl fumarate
,
Fingolimod hydrochloride
,
Glatiramer acetate
,
Ocrelizumab
,
Natalizumab
,
Ofatumumab
,
Fingolimod
,
Teriflunomide
,
Ponesimod
,
Fingolimod lauryl sulfate
💬
| [26] DHODH DHODH, HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬
| [58] Allograft rejection Allograft rejection, Antigen processing and presentation, Arrhythmogenic right ventricular cardiomyopathy, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Phagocytosis, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [1] 13 13 💬
|
| 771 | Interferón beta 1a | - | - | - | - | [1] 13 13 💬
|
| 772 | Interferón beta 1a pegilado | - | - | - | - | [1] 13 13 💬
|
| 773 | Interferón Beta-1a pegilado | - | - | - | - | [1] 13 13 💬
|
| 774 | Interlaminar ultrasound-assisted intrathecal administration of nusinersen | [1] Nusinersen Nusinersen | [2] Nusinersen sodium
Nusinersen sodium
,
Nusinersen
💬
| - | - | [1] 3 3 💬
|
| 775 | Interleukin 10 | - | - | - | - | [2] 46 46, 63 💬
|
| 776 | Interleukin 2 | - | - | - | - | [9] 46 46, 49, 51, 56, 63, 95, 96, 97, 271 💬
|
| 777 | Interleukin 23 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 778 | Interleukin 4 | - | - | - | - | [1] 46 46 💬
|
| 779 | Interleukin-2 | - | - | - | - | [6] 2 2, 13, 49, 50, 55, 65 💬
|
| 780 | Interleukin-2 (aldesleukin). | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 96 96, 97 💬
|
| 781 | Interleukin-23 Inhibitors (IL-23i) | - | - | - | - | [1] 97 97 💬
|
| 782 | Interleukin-7 | [1] Interleukin-7 Interleukin-7 | - | - | - | [1] 25 25 💬
|
| 783 | Interleukine-2 | - | - | - | - | [1] 61 61 💬
|
| 784 | Intermediate dose BIBF 1120 twice daily | - | - | - | - | [1] 85 85 💬
|
| 785 | Intermittent Exposure to Oxygen via Oro-Nasal Mask | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 226 226 💬
|
| 786 | Intermittent Moxifloxacin + Standard Care | [1] Moxifloxacin Moxifloxacin | [3] Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
,
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | [1] 299 299 💬
|
| 787 | Intermittent theta burst stimulation (iTBS) therapeutic protocol for spasticity | - | - | - | - | [1] 13 13 💬
|
| 788 | Intermittent, short infusion Cefepime | [1] Cefepime Cefepime | [2] Cefepime hydrochloride
Cefepime hydrochloride
,
Cefepime
💬
| - | - | [1] 299 299 💬
|
| 789 | Intermittent, short infusion Ceftazidime | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | [1] 299 299 💬
|
| 790 | Intermittent, short infusion Meropenem | [1] Meropenem Meropenem | [2] Meropenem
Meropenem
,
Meropenem
💬
| - | - | [1] 299 299 💬
|
| 791 | Intermittent, short infusion Piperacillin tazobactam | [2] Piperacillin Piperacillin, Tazobactam | [5] Piperacillin sodium
Piperacillin sodium
,
Tazobactam
,
Piperacillin
,
Tazobactam sodium
,
Piperacillin
💬
| - | - | [1] 299 299 💬
|
| 792 | Intermittent, short infusion Ticarcillin-clavulanate | [1] Ticarcillin Ticarcillin | [2] Ticarcillin disodium
Ticarcillin disodium
,
Ticarcillin
💬
| - | - | [1] 299 299 💬
|
| 793 | Intervention for incipient patients at low risk of disease progression | - | - | - | - | [1] 66 66 💬
|
| 794 | Intervention for patients at high risk of disease progression | - | - | - | - | [1] 66 66 💬
|
| 795 | Intervention/Treatment | - | - | - | - | [1] 75 75 💬
|
| 796 | Intervention: Ketamine | [1] Ketamine Ketamine | [2] Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 797 | Intestinal biopsies | - | - | - | - | [2] 96 96, 97 💬
|
| 798 | Intestinal flora capsule | - | - | - | - | [1] 97 97 💬
|
| 799 | Intestinal microbiota transplant (IMT) | - | - | - | - | [1] 86 86 💬
|
| 800 | Intestinal resection | - | - | - | - | [1] 96 96 💬
|
| 801 | Intestinal surgery for Crohn's Disease | - | - | - | - | [1] 96 96 💬
|
| 802 | Intestinal ultrasound | - | - | - | - | [1] 96 96 💬
|
| 803 | Intra Plexus Triamcinolone and Bupivicaine Injection | [1] Triamcinolone Triamcinolone | [4] Triamcinolone
Triamcinolone
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 298 298 💬
|
| 804 | Intra venous injection of stem cell | - | - | - | - | [1] 2 2 💬
|
| 805 | Intra-articular Compound Betamethasone | [1] Betamethasone Betamethasone | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
,
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 806 | Intra-articular corticosteroid injection | - | - | - | - | [1] 46 46 💬
|
| 807 | Intra-articular injection of etanercept | [1] Etanercept Etanercept | [1] Etanercept
Etanercept
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 808 | Intra-articular injection of steroid | - | - | - | - | [1] 46 46 💬
|
| 809 | Intra-articular steroid injection | - | - | - | - | [1] 107 107 💬
|
| 810 | Intra-articular Tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬
|
| 811 | Intra-detrusor injection of Onabotulinumtoxin-A | - | - | - | - | [1] 13 13 💬
|
| 812 | Intraarticular betamethasone | [1] Betamethasone Betamethasone | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
,
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 813 | Intraarticular dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 814 | Intraarticular injection | - | - | - | - | [1] 46 46 💬
|
| 815 | Intraarticular morphine | [1] Morphine Morphine | [4] Morphine sulfate
Morphine sulfate
,
Morphine hydrochloride hydrate
,
Morphine
,
Morphine tartrate
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 816 | Intracerebral microinjections | - | - | - | - | [1] 6 6 💬
|
| 817 | Intracoronary administration of umbilical cord-derived MSCs | - | - | - | - | [1] 57 57 💬
|
| 818 | Intralesional Injection of Bleomycin | [1] Bleomycin Bleomycin | [3] Bleomycin sulfate
Bleomycin sulfate
,
Bleomycin hydrochloride
,
Bleomycin
💬
| - | - | [1] 278 278 💬
|
| 819 | Intralipid | - | - | - | - | [1] 96 96 💬
|
| 820 | Intralipid 10% | - | - | - | - | [1] 96 96 💬
|
| 821 | Intralipid 20% | - | - | - | - | [1] 96 96 💬
|
| 822 | Intralipid, 20% Intravenous Emulsion | - | - | - | - | [1] 48 48 💬
|
| 823 | Intralipid/Heparin | [1] Heparin Heparin | [2] Heparin sodium
Heparin sodium
,
Heparin calcium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [3] 316 316, 317, 344 💬
|
| 824 | Intraluminal Impedance | - | - | - | - | [1] 98 98 💬
|
| 825 | Intranasal Foralumab Solution | [1] Foralumab Foralumab | - | - | - | [1] 13 13 💬
|
| 826 | Intranasal glutathione - (in)GSH | [1] Glutathione Glutathione | [1] Glutathione
Glutathione
💬
| - | - | [1] 6 6 💬
|
| 827 | Intranasal infusion | - | - | - | - | [1] 18 18 💬
|
| 828 | Intranasal Insulin | - | - | - | - | [2] 6 6, 17 💬
|
| 829 | Intranasal OXT | - | - | - | - | [1] 72 72 💬
|
| 830 | Intranasal oxytocin | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [2] 127 127, 193 💬
|
| 831 | Intranasal Oxytocin (IN-OXT) | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 193 193 💬
|
| 832 | Intraoperative ANI Monitoring | - | - | - | - | [1] 70 70 💬
|
| 833 | Intrapulmonary percussive ventilation | - | - | - | - | [1] 85 85 💬
|
| 834 | Intratect | - | - | - | - | [4] 13 13, 14, 35, 65 💬
|
| 835 | Intratect 5% | - | - | - | - | [1] 35 35 💬
|
| 836 | Intrathalamic AAV.PGRN administration | - | - | - | - | [1] 127 127 💬
|
| 837 | Intrathecal (IT) | - | - | - | - | [1] 6 6 💬
|
| 838 | Intrathecal administration of autologous MSC-NP | - | - | - | - | [1] 13 13 💬
|
| 839 | Intrathecal autologous stem cell | - | - | - | - | [1] 2 2 💬
|
| 840 | Intrathecal infusion | - | - | - | - | [1] 18 18 💬
|
| 841 | Intrathecal injection | - | - | - | - | [2] 2 2, 18 💬
|
| 842 | Intrathecal methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 13 13 💬
|
| 843 | Intrathecal MSC-NP injection | - | - | - | - | [1] 13 13 💬
|
| 844 | Intrathecal recombinant human alpha iduronidase | - | - | - | - | [1] 19 19 💬
|
| 845 | Intrathecal Riluzole | [1] Riluzole Riluzole | [1] Riluzole
Riluzole
💬
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [24] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 846 | Intravenous | - | - | - | - | [1] 6 6 💬
|
| 847 | Intravenous (i.v.) methylprednisolone 1000 mg, total 9 | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 222 222, 223 💬
|
| 848 | Intravenous (IV) Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 849 | Intravenous (IV) infusions | - | - | - | - | [2] 13 13, 97 💬
|
| 850 | Intravenous administration of 1 million of MSC | - | - | - | - | [1] 2 2 💬
|
| 851 | Intravenous administration of 2 million of MSC | - | - | - | - | [1] 2 2 💬
|
| 852 | Intravenous administration of 4 million of MSC | - | - | - | - | [1] 2 2 💬
|
| 853 | Intravenous administration of ferric carboxymaltose | [1] Ferric carboxymaltose Ferric carboxymaltose | [1] Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | [1] 86 86 💬
|
| 854 | Intravenous administration of PTH1-84 mRNA | - | - | - | - | [1] 235 235 💬
|
| 855 | Intravenous Bacteriophage Cocktail plus Standard IV Antibiotics | - | - | - | - | [1] 299 299 💬
|
| 856 | Intravenous bone marrow mesenchymal stem cells infusion | - | - | - | - | [1] 60 60 💬
|
| 857 | Intravenous catheter | - | - | - | - | [1] 231 231 💬
|
| 858 | Intravenous Dexamethasone 1 mg | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 859 | Intravenous gammaglobulin | - | - | - | - | [1] 14 14 💬
|
| 860 | Intravenous Glucocorticoids | - | - | - | - | [1] 13 13 💬
|
| 861 | Intravenous immune globulin | - | - | - | - | [1] 256 256 💬
|
| 862 | Intravenous immune globulin G | - | - | - | - | [1] 14 14 💬
|
| 863 | Intravenous ImmuneGlobulin | - | - | - | - | [1] 11 11 💬
|
| 864 | Intravenous Immunoglobulin | - | - | - | - | [9] 13 13, 14, 35, 38, 39, 49, 51, 63, 309 💬
|
| 865 | Intravenous immunoglobulin (IVIg) | - | - | - | - | [8] 14 14, 17, 19, 63, 65, 85, 164, 296 💬
|
| 866 | Intravenous immunoglobulin (IVIG), 10% solution for infusion | - | - | - | - | [2] 2 2, 63 💬
|
| 867 | Intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬
|
| 868 | Intravenous immunoglobulin infusion | - | - | - | - | [1] 65 65 💬
|
| 869 | Intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO) | [2] Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Thrombopoietin | - | - | - | [1] 63 63 💬
|
| 870 | Intravenous immunoglobulins | - | - | - | - | [1] 63 63 💬
|
| 871 | Intravenous immunoglobulins (human immunoglobulins G) | - | - | - | - | [1] 43 43 💬
|
| 872 | Intravenous Infusion | - | - | - | - | [3] 6 6, 18, 51 💬
|
| 873 | Intravenous Infusion of Diclofenac Sodium | [1] Diclofenac Diclofenac | [5] Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 78 78 💬
|
| 874 | Intravenous infusion of MSCs | - | - | - | - | [1] 271 271 💬
|
| 875 | Intravenous infusion of transduced cells | - | - | - | - | [1] 65 65 💬
|
| 876 | Intravenous injection | - | - | - | - | [2] 2 2, 222 💬
|
| 877 | Intravenous injection autologous mesenchymal stem cells | - | - | - | - | [1] 67 67 💬
|
| 878 | Intravenous injection of mesenchymal stem cells | - | - | - | - | [1] 13 13 💬
|
| 879 | Intravenous iron | - | - | - | - | [1] 97 97 💬
|
| 880 | Intravenous iron sucrose | [2] Iron sucrose Iron sucrose, Sucrose | [2] Sucrose
Sucrose
,
Iron sucrose
💬
| - | - | [1] 97 97 💬
|
| 881 | Intravenous Levodopa | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 882 | Intravenous methyl prednisolone | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 💬
|
| 883 | Intravenous Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 97, 145 💬
|
| 884 | Intravenous Methylprednisolone (IVMP) | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 885 | Intravenous methylprednisolone (IVMP) and Efgartigimod | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 886 | Intravenous midazolam (3 mg initially, with optional 3 mg boluses) plus fentanyl (100 mcg) for procedural sedation. | [2] Fentanyl Fentanyl, Midazolam | [6] Fentanyl
Fentanyl
,
Midazolam
,
Midazolam hydrochloride
,
Fentanyl citrate
,
Midazolam maleate
,
Fentanyl hydrochloride
💬
| [17] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, OPRM1 💬
| [11] Cadherin signaling Cadherin signaling, Estrogen signaling pathway, GABAergic synapse, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 97 97 💬
|
| 887 | Intravenous remimazolam (5 mg initially, with optional 2.5 mg boluses) plus fentanyl (100 mcg) for procedural sedation. | [2] Fentanyl Fentanyl, Remimazolam | [5] Fentanyl
Fentanyl
,
Fentanyl citrate
,
Remimazolam besylate
,
Fentanyl hydrochloride
,
Remimazolam
💬
| [17] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, OPRM1 💬
| [11] Cadherin signaling Cadherin signaling, Estrogen signaling pathway, GABAergic synapse, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 97 97 💬
|
| 888 | Intravenous Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 66 66 💬
|
| 889 | Intravenous steroid | - | - | - | - | [1] 13 13 💬
|
| 890 | Intravenous Treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 891 | Intravenous/Subcutaneous Treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 892 | Intraventricular Access Device | - | - | - | - | [1] 19 19 💬
|
| 893 | Intraventricular injection | - | - | - | - | [1] 2 2 💬
|
| 894 | Intravesical injection of Botulinum A toxin | - | - | - | - | [2] 6 6, 17 💬
|
| 895 | Intravesical injection of Platlet Rich Plasma (PRP) | - | - | - | - | [1] 226 226 💬
|
| 896 | Intravesical onabotulinumtoxinA injection | - | - | - | - | [1] 226 226 💬
|
| 897 | Intravesical sodium hyaluronate (Cystistat®) | [1] Hyaluronic acid Hyaluronic acid | [2] Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | [1] 226 226 💬
|
| 898 | Intravitreal Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 90 90 💬
|
| 899 | Intravitreal autologous CD34+ cells | - | - | - | - | [1] 90 90 💬
|
| 900 | Intravitreal Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 56 56 💬
|
| 901 | Intravitreal injection of Autologous bone marrow Stem Cell | - | - | - | - | [1] 90 90 💬
|
| 902 | Intravitreal injection of autologous bone marrow stem cells | - | - | - | - | [1] 90 90 💬
|
| 903 | Intravitreal Injection of Ultevursen | [1] Ultevursen Ultevursen | - | - | - | [2] 90 90, 303 💬
|
| 904 | Intravitreal injection ranibizumab | [1] Ranibizumab Ranibizumab | [1] Ranibizumab
Ranibizumab
💬
| [1] VEGFA VEGFA 💬
| [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1] 166 166 💬
|
| 905 | Intrinsically labelled protein | - | - | - | - | [1] 96 96 💬
|
| 906 | Intubated with Propofol (IP) | [1] Propofol Propofol | [1] Propofol
Propofol
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 98 98 💬
|
| 907 | Intubated with Sevoflurane (IS) | [1] Sevoflurane Sevoflurane | [1] Sevoflurane
Sevoflurane
💬
| - | - | [1] 98 98 💬
|
| 908 | Inulin | [1] Inulin Inulin | [1] Inulin
Inulin
💬
| - | - | [5] 6 6, 96, 97, 156, 299 💬
|
| 909 | Inulin Sachet | [1] Inulin Inulin | [1] Inulin
Inulin
💬
| - | - | [1] 97 97 💬
|
| 910 | Inulin, B-vitamins and vitamin D | [2] Inulin Inulin, Vitamin D | [1] Inulin
Inulin
💬
| - | - | [1] 6 6 💬
|
| 911 | Inulin/Inulin C13 | [1] Inulin Inulin | [1] Inulin
Inulin
💬
| - | - | [2] 96 96, 97 💬
|
| 912 | INV-101 | - | - | - | - | [1] 97 97 💬
|
| 913 | Investigational Product | - | - | - | - | [1] 96 96 💬
|
| 914 | Investigators Choice of Approved AED | - | - | - | - | [1] 144 144 💬
|
| 915 | Investigators choice of approved AEDs | - | - | - | - | [1] 144 144 💬
|
| 916 | INVIRASE | - | - | - | - | [2] 222 222, 223 💬
|
| 917 | InVita D3 | - | - | - | - | [1] 96 96 💬
|
| 918 | INZ-701 | [1] INZ-701 INZ-701 | - | - | - | [1] 166 166 💬
|
| 919 | Inzomelid | - | - | - | - | [1] 106 106 💬
|
| 920 | Iodide | [1] Iodide Iodide | - | - | - | [1] 34 34 💬
|
| 921 | Iodine | [1] Iodine Iodine | [1] Iodine
Iodine
💬
| - | - | [5] 28 28, 46, 88, 96, 118 💬
|
| 922 | IODIO IOFLUPANO-123I | - | - | - | - | [1] 6 6 💬
|
| 923 | Ioexolo | - | - | - | - | [1] 222 222 💬
|
| 924 | Ioflupane | - | - | - | - | [1] 6 6 💬
|
| 925 | IOFLUPANE (123I) | - | - | - | - | [1] 6 6 💬
|
| 926 | Ioflupane 123I | - | - | - | - | [1] 2 2 💬
|
| 927 | Ioflupane 123I (DATSCAN®) | - | - | - | - | [1] 6 6 💬
|
| 928 | Ioflupane [123 I] | - | - | - | - | [1] 6 6 💬
|
| 929 | Ioflupane [123I] | - | - | - | - | [1] 6 6 💬
|
| 930 | Ioflupane I 123 | - | - | - | - | [1] 6 6 💬
|
| 931 | Iohexol | [1] Iohexol Iohexol | [1] Iohexol
Iohexol
💬
| - | - | [2] 19 19, 67 💬
|
| 932 | Iohexol Inj 300 milligrams per milliliter (MG/ML) | [1] Iohexol Iohexol | [1] Iohexol
Iohexol
💬
| - | - | [1] 67 67 💬
|
| 933 | ION-682884 | - | - | - | - | [1] 28 28 💬
|
| 934 | ION-682884Product Code: ION-682884Pharmaceutical Form: Solution for injectionINN or Proposed INN: eplontersenCAS Number: 1637600-16-8Current Sponsor code: ION-682884Other descriptive name: AKCEA-TTR-LRxConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 28 28 💬
|
| 935 | ION283 | [1] ION283 ION283 | - | - | - | [1] 309 309 💬
|
| 936 | ION337 | - | - | - | - | [1] 140 140 💬
|
| 937 | ION356 | [1] ION356 ION356 | - | - | - | [1] 139 139 💬
|
| 938 | ION363 | - | - | - | - | [1] 2 2 💬
|
| 939 | ION363 SODIUM | - | - | - | - | [1] 2 2 💬
|
| 940 | ION373 | - | - | - | - | [1] 131 131 💬
|
| 941 | ION440 | - | - | - | - | [1] 339 339 💬
|
| 942 | ION464 | - | - | - | - | [1] 17 17 💬
|
| 943 | ION582 | [1] ION582 ION582 | - | - | - | [1] 201 201 💬
|
| 944 | ION717 | - | - | - | - | [1] 23 23 💬
|
| 945 | IONIS ANGPTL3-LRx | - | - | - | - | [1] 79 79 💬
|
| 946 | IONIS GHR-LRx | - | - | - | - | [1] 77 77 💬
|
| 947 | IONIS-DMPKRx | - | - | - | - | [1] 113 113 💬
|
| 948 | IONIS-ENaCRx | - | - | - | - | [1] 299 299 💬
|
| 949 | IONIS-FB-LRx | - | - | - | - | [1] 66 66 💬
|
| 950 | IONIS-GHR-LRx | - | - | - | - | [1] 77 77 💬
|
| 951 | Iontophoresis of treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 952 | Iowa Oral Performance Instrument | - | - | - | - | [1] 2 2 💬
|
| 953 | Iowa Oral Pressure Instrument | - | - | - | - | [1] 2 2 💬
|
| 954 | IP6 | - | - | - | - | [1] 122 122 💬
|
| 955 | IPC | - | - | - | - | [1] 75 75 💬
|
| 956 | IPD® (Japanese tradename) | - | - | - | - | [1] 226 226 💬
|
| 957 | IPD® (suplatast tosilate) | [1] Suplatast Suplatast | [1] Suplatast tosilate
Suplatast tosilate
💬
| - | - | [1] 226 226 💬
|
| 958 | IPG11406 | - | - | - | - | [1] 97 97 💬
|
| 959 | IPH5401 | - | - | - | - | [1] 162 162 💬
|
| 960 | IPI 145 | - | - | - | - | [1] 46 46 💬
|
| 961 | IPI-145 | - | - | - | - | [1] 46 46 💬
|
| 962 | Ipilimumab | [1] Ipilimumab Ipilimumab | [1] Ipilimumab
Ipilimumab
💬
| [1] CTLA4 CTLA4 💬
| [4] Autoimmune thyroid disease Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Rheumatoid arthritis, T cell receptor signaling pathway 💬 | [9] 13 13, 46, 49, 50, 51, 53, 96, 97, 159 💬
|
| 963 | IPL344 | - | - | - | - | [1] 2 2 💬
|
| 964 | IPN60120 | - | - | - | - | [1] 272 272 💬
|
| 965 | IPN60130 | - | - | - | - | [1] 272 272 💬
|
| 966 | IPN60130 10 mg capsules | - | - | - | - | [1] 272 272 💬
|
| 967 | IPN60130 50 mg capsules | - | - | - | - | [1] 272 272 💬
|
| 968 | IPN60190 | - | - | - | - | [2] 93 93, 94 💬
|
| 969 | IPP - 201101 | - | - | - | - | [1] 49 49 💬
|
| 970 | IPP-201101 | - | - | - | - | [1] 49 49 💬
|
| 971 | IPP-201101, P140 | - | - | - | - | [1] 49 49 💬
|
| 972 | Ipratropium | [1] Ipratropium Ipratropium | - | - | - | [2] 6 6, 86 💬
|
| 973 | Ipratropium bromide (drug) | [1] Ipratropium Ipratropium | - | - | - | [1] 6 6 💬
|
| 974 | IPRONIAZID | [1] Iproniazid Iproniazid | [2] Iproniazid
Iproniazid
,
Iproniazid phosphate
💬
| [2] MAOA MAOA, MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 975 | Ips-nsc cells | - | - | - | - | [1] 6 6 💬
|
| 976 | IPS101A | - | - | - | - | [1] 6 6 💬
|
| 977 | IPSC-CL | - | - | - | - | [1] 210 210 💬
|
| 978 | IPSC-EVs | - | - | - | - | [1] 22 22 💬
|
| 979 | IPSC-MNP | - | - | - | - | [1] 2 2 💬
|
| 980 | IPSTYL | - | - | - | - | [1] 77 77 💬
|
| 981 | IPSTYL - 60 MG SOLUZIONE INIETTABILE PER USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA | - | - | - | - | [1] 77 77 💬
|
| 982 | IPSTYL - 90 MG SOLUZIONE INIETTABILE PER USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA | - | - | - | - | [1] 77 77 💬
|
| 983 | Ipstyl 120 mg | - | - | - | - | [1] 77 77 💬
|
| 984 | Ipstyl 90 mg | - | - | - | - | [1] 77 77 💬
|
| 985 | Ipstyl Autogel | - | - | - | - | [1] 77 77 💬
|
| 986 | IPT803 | - | - | - | - | [1] 6 6 💬
|
| 987 | Iptacopan | [1] Iptacopan Iptacopan | [2] Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [8] 11 11, 61, 62, 63, 66, 109, 222, 223 💬
|
| 988 | Iptacopan (LNP023) | [1] Iptacopan Iptacopan | [2] Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [1] 62 62 💬
|
| 989 | Iptacopan hydrochloride | [1] Iptacopan Iptacopan | [2] Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [5] 61 61, 63, 66, 109, 223 💬
|
| 990 | Iptcaopan 200 mg | - | - | - | - | [1] 109 109 💬
|
| 991 | IPX054 100 mg | - | - | - | - | [1] 6 6 💬
|
| 992 | IPX054 150 mg | - | - | - | - | [1] 6 6 💬
|
| 993 | IPX054 200 mg | - | - | - | - | [1] 6 6 💬
|
| 994 | IPX054 250 mg | - | - | - | - | [1] 6 6 💬
|
| 995 | IPX054 300 mg | - | - | - | - | [1] 6 6 💬
|
| 996 | IPX056 | - | - | - | - | [1] 13 13 💬
|
| 997 | IPX056 10 mg | - | - | - | - | [1] 13 13 💬
|
| 998 | IPX056 20 mg | - | - | - | - | [1] 13 13 💬
|
| 999 | IPX056 30 mg | - | - | - | - | [1] 13 13 💬
|
| 1000 | IPX056 35 mg | - | - | - | - | [1] 13 13 💬
|
| 1001 | IPX056 40 mg | - | - | - | - | [1] 13 13 💬
|
| 1002 | IPX056-10 mg | - | - | - | - | [1] 13 13 💬
|
| 1003 | IPX056-20 mg | - | - | - | - | [1] 13 13 💬
|
| 1004 | IPX056-25 mg | - | - | - | - | [1] 13 13 💬
|
| 1005 | IPX056-30 mg | - | - | - | - | [1] 13 13 💬
|
| 1006 | IPX056-35 mg | - | - | - | - | [1] 13 13 💬
|
| 1007 | IPX056-40 mg | - | - | - | - | [1] 13 13 💬
|
| 1008 | IPX066 | - | - | - | - | [1] 6 6 💬
|
| 1009 | IPX066 145 mg | - | - | - | - | [1] 6 6 💬
|
| 1010 | IPX066 145 mg LD | - | - | - | - | [1] 6 6 💬
|
| 1011 | IPX066 195 mg | - | - | - | - | [1] 6 6 💬
|
| 1012 | IPX066 195 mg LD | - | - | - | - | [1] 6 6 💬
|
| 1013 | IPX066 245 mg | - | - | - | - | [1] 6 6 💬
|
| 1014 | IPX066 245 mg LD | - | - | - | - | [1] 6 6 💬
|
| 1015 | IPX066 95 mg | - | - | - | - | [1] 6 6 💬
|
| 1016 | IPX066 95 mg LD | - | - | - | - | [1] 6 6 💬
|
| 1017 | IPX066-145 | - | - | - | - | [1] 6 6 💬
|
| 1018 | IPX066-195 | - | - | - | - | [1] 6 6 💬
|
| 1019 | IPX066-245 | - | - | - | - | [1] 6 6 💬
|
| 1020 | IPX066-95 | - | - | - | - | [1] 6 6 💬
|
| 1021 | IPX203 | - | - | - | - | [1] 6 6 💬
|
| 1022 | IPX203 140 mg | - | - | - | - | [1] 6 6 💬
|
| 1023 | IPX203 180 mg | - | - | - | - | [1] 6 6 💬
|
| 1024 | IPX203 210 mg | - | - | - | - | [1] 6 6 💬
|
| 1025 | IPX203 270 mg | - | - | - | - | [1] 6 6 💬
|
| 1026 | IPX203 280 mg | - | - | - | - | [1] 6 6 💬
|
| 1027 | IPX203 350 mg | - | - | - | - | [1] 6 6 💬
|
| 1028 | IPX203 ER CD-LD | - | - | - | - | [1] 6 6 💬
|
| 1029 | IQYMUNE | - | - | - | - | [1] 14 14 💬
|
| 1030 | IR CD-LD | - | - | - | - | [1] 6 6 💬
|
| 1031 | IR CD-LD (carbidopa-levodopa) tablets | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1032 | IR LD / CD | - | - | - | - | [1] 6 6 💬
|
| 1033 | IR LD/CD | - | - | - | - | [1] 6 6 💬
|
| 1034 | IR Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 1035 | IR902 | - | - | - | - | [1] 13 13 💬
|
| 1036 | IRAK 4 | - | - | - | - | [1] 46 46 💬
|
| 1037 | IRBD | - | - | - | - | [1] 6 6 💬
|
| 1038 | Irbesartan | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [6] 57 57, 66, 167, 168, 222, 223 💬
|
| 1039 | Irbesartan 150-300mg capsules daily for 6 months | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 167 167 💬
|
| 1040 | Irbesartan tablets | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 💬
|
| 1041 | Irbesartan tablets (Approved in the USA. Reference listed drug Avapro) NDC # 43547-0374-03 | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 💬
|
| 1042 | Irbesartan tablets (Approved in the USA. Reference listed drug Avapro) NDC # 43547-0374-03Product Name: over-encapsulated 75 mg Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75- | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1043 | Irbesartan tablets (NDC# 43547-0374-03 and NDC 43547-374-09, approved in the USA) Generic tablets distributed by Solco Healthcare US, LLCProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Trade Name: Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-Trade Name: Irbesartan tablets (NDC# 31722-729-30 approved in the United states)Product Name: Over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021O | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1044 | Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Trade Name: Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-Trade Name: Irbesartan tabletsProduct Name: Over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 400- | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1045 | Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Trade Name: Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-Trade Name: Irbesartan tabletsProduct Name: Over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 400- | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1046 | Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Trade Name: Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-Trade Name: Irbesartan tabletsProduct Name: Over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 400- | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1047 | IRL201104 | - | - | - | - | [1] 98 98 💬
|
| 1048 | IRL201805 | - | - | - | - | [1] 46 46 💬
|
| 1049 | IRL752 | - | - | - | - | [1] 6 6 💬
|
| 1050 | IRL757 | - | - | - | - | [1] 6 6 💬
|
| 1051 | IRL790 | - | - | - | - | [1] 6 6 💬
|
| 1052 | IRM | - | - | - | - | [2] 72 72, 225 💬
|
| 1053 | Iron | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [7] 18 18, 60, 96, 97, 238, 254, 284 💬
|
| 1054 | Iron (III) hydroxide hydroxyethyl starch glucopheptonic acid complex | [2] Hydroxyethyl Starch Hydroxyethyl Starch, Iron | [2] Ferrous fumarate
Ferrous fumarate
,
Hetastarch
💬
| - | - | [1] 97 97 💬
|
| 1055 | IRON CHELATING AGENTS | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 284 284 💬
|
| 1056 | Iron chelating intervention | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 18 18 💬
|
| 1057 | Iron Dextran | [3] Dextran Dextran, Iron, Iron Dextran | [7] Dextran 1
Dextran 1
,
Ferrous fumarate
,
Dextran sulfate sodium
,
Iron dextran
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [2] 62 62, 97 💬
|
| 1058 | Iron HES Complex | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1059 | Iron integrated haemolysed haemoglobin powderequal to 18 mg Fe++ | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1060 | Iron isomalto-oligosaccharide complex | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1061 | Iron Isomaltoside | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1062 | IRON ISOMALTOSIDE 1000 | [2] Iron Iron, Iron isomaltoside 1000 | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1063 | Iron isomaltoside complex - Iron Isomaltoside 1000 | [2] Iron Iron, Iron isomaltoside 1000 | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1064 | Iron oligosaccharide complex | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1065 | Iron sucrose | [3] Iron Iron, Iron sucrose, Sucrose | [3] Sucrose
Sucrose
,
Ferrous fumarate
,
Iron sucrose
💬
| - | - | [3] 62 62, 96, 97 💬
|
| 1066 | Iron Sucrose. | [3] Iron Iron, Iron sucrose, Sucrose | [3] Sucrose
Sucrose
,
Ferrous fumarate
,
Iron sucrose
💬
| - | - | [1] 97 97 💬
|
| 1067 | Iron Sulfate | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1068 | Iron sulphate | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [2] 96 96, 97 💬
|
| 1069 | Iron sulphate 200mg coated tablets | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [2] 96 96, 97 💬
|
| 1070 | Iron supplement | - | - | - | - | [1] 86 86 💬
|
| 1071 | Iron supplement 300-600 mg/day | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [2] 96 96, 97 💬
|
| 1072 | Iron supplementation | - | - | - | - | [1] 240 240 💬
|
| 1073 | Iron trivalent | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1074 | IRON(III) ISOMALTOSIDE 1000 | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1075 | Iron(III)- hydroxide dextran complex | [2] Dextran Dextran, Iron | [6] Dextran 1
Dextran 1
,
Ferrous fumarate
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1076 | IRON(III)-HYDROXIDE DEXTRAN COMPLEX | [1] Dextran Dextran | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [1] 97 97 💬
|
| 1077 | Irradiation | - | - | - | - | [1] 13 13 💬
|
| 1078 | IRT Laronidase | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬
| [1] IDUA IDUA 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 1079 | IRX4204 | - | - | - | - | [1] 6 6 💬
|
| 1080 | Isaralgagene civaparvovec | [1] Isaralgagene civaparvovec Isaralgagene civaparvovec | - | - | - | [1] 19 19 💬
|
| 1081 | Isatuximab | [1] Isatuximab Isatuximab | [1] Isatuximab
Isatuximab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [3] 28 28, 61, 283 💬
|
| 1082 | Isatuximab SAR650984 | [1] Isatuximab Isatuximab | [1] Isatuximab
Isatuximab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 61 61 💬
|
| 1083 | ISC-hpNSC | - | - | - | - | [1] 6 6 💬
|
| 1084 | Iscalimab | [1] Iscalimab Iscalimab | [1] Iscalimab
Iscalimab
💬
| [1] CD40 CD40 💬
| [17] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | [2] 49 49, 53 💬
|
| 1085 | ISENTRESS | - | - | - | - | [1] 13 13 💬
|
| 1086 | Isicom | - | - | - | - | [1] 6 6 💬
|
| 1087 | ISIS 104838 | [1] ISIS 104838 ISIS 104838 | - | - | - | [1] 46 46 💬
|
| 1088 | ISIS 301012 | - | - | - | - | [1] 79 79 💬
|
| 1089 | ISIS 301012 phosphorothioate oligonucleotide | - | - | - | - | [1] 79 79 💬
|
| 1090 | ISIS 304801 | - | - | - | - | [1] 265 265 💬
|
| 1091 | ISIS 333611 | - | - | - | - | [1] 2 2 💬
|
| 1092 | ISIS 396443 | - | - | - | - | [1] 3 3 💬
|
| 1093 | ISIS 396443 (BIIB058) | - | - | - | - | [1] 3 3 💬
|
| 1094 | ISIS 396443, BIIB058 | - | - | - | - | [1] 3 3 💬
|
| 1095 | ISIS 420915 | - | - | - | - | [1] 28 28 💬
|
| 1096 | Isis 420915/GSK 299872 | - | - | - | - | [1] 28 28 💬
|
| 1097 | ISIS 443139 10 mg | - | - | - | - | [1] 8 8 💬
|
| 1098 | ISIS 443139 120 mg | - | - | - | - | [1] 8 8 💬
|
| 1099 | ISIS 443139 30 mg | - | - | - | - | [1] 8 8 💬
|
| 1100 | ISIS 443139 60 mg | - | - | - | - | [1] 8 8 💬
|
| 1101 | ISIS 443139 90 mg | - | - | - | - | [1] 8 8 💬
|
| 1102 | ISIS 703802 | - | - | - | - | [1] 79 79 💬
|
| 1103 | ISIS 721744 | - | - | - | - | [1] 65 65 💬
|
| 1104 | ISIS 721744Pharmaceutical Form: Solution for injection | - | - | - | - | [1] 65 65 💬
|
| 1105 | ISIS 766720 | - | - | - | - | [1] 77 77 💬
|
| 1106 | ISIS CRP Rx | - | - | - | - | [1] 46 46 💬
|
| 1107 | ISM5411 tablets | - | - | - | - | [1] 97 97 💬
|
| 1108 | Isocaloric Diet | - | - | - | - | [2] 2 2, 83 💬
|
| 1109 | Isofagamine tartrate | - | - | - | - | [1] 19 19 💬
|
| 1110 | Isoflavone | [1] Isoflavone Isoflavone | - | - | - | [2] 96 96, 97 💬
|
| 1111 | Isoflurane | [1] Isoflurane Isoflurane | [1] Isoflurane
Isoflurane
💬
| - | - | [1] 6 6 💬
|
| 1112 | Isoleucine | [1] Isoleucine Isoleucine | [1] Isoleucine
Isoleucine
💬
| - | - | [1] 244 244 💬
|
| 1113 | Isolex 300i Magnetic Cell Selector | - | - | - | - | [1] 65 65 💬
|
| 1114 | Isoniazid | [1] Isoniazid Isoniazid | [1] Isoniazid
Isoniazid
💬
| - | - | [2] 49 49, 254 💬
|
| 1115 | Isoniazid/Pyridoxine | [2] Isoniazid Isoniazid, Pyridoxine | [3] Isoniazid
Isoniazid
,
Pyridoxine hydrochloride
,
Pyridoxine
💬
| - | - | [1] 49 49 💬
|
| 1116 | Isoptin | - | - | - | - | [1] 58 58 💬
|
| 1117 | Isosorbide | [1] Isosorbide Isosorbide | [1] Isosorbide
Isosorbide
💬
| - | - | [1] 113 113 💬
|
| 1118 | ISOSORBIDE DINITRATE | [2] Isosorbide Isosorbide, Isosorbide dinitrate | [2] Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | [1] 113 113 💬
|
| 1119 | Isosorbide Dinitrate 20 mg | [2] Isosorbide Isosorbide, Isosorbide dinitrate | [2] Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | [1] 113 113 💬
|
| 1120 | Isosorbide Dinitrate 40 mg | [2] Isosorbide Isosorbide, Isosorbide dinitrate | [2] Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | [1] 113 113 💬
|
| 1121 | Isosorbide Dinitrate 60 mg | [2] Isosorbide Isosorbide, Isosorbide dinitrate | [2] Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | [1] 113 113 💬
|
| 1122 | Isosorbide Dinitrate 80 mg | [2] Isosorbide Isosorbide, Isosorbide dinitrate | [2] Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | [1] 113 113 💬
|
| 1123 | Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung | - | - | - | - | [1] 50 50 💬
|
| 1124 | ISOTONIC SALINE | - | - | - | - | [1] 299 299 💬
|
| 1125 | Isotonic saline 0.9% | - | - | - | - | [1] 299 299 💬
|
| 1126 | Isotopic Intravenous [13C]-Urea | [1] Urea Urea | [2] Urea
Urea
,
Urea C13
💬
| - | - | [1] 251 251 💬
|
| 1127 | Isotretinoin | [1] Isotretinoin Isotretinoin | [1] Isotretinoin
Isotretinoin
💬
| [2] RARA RARA, RARB 💬
| [8] Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [4] 36 36, 39, 159, 160 💬
|
| 1128 | ISOTRETINOINA | - | - | - | - | [1] 160 160 💬
|
| 1129 | Isoxsuprine | [1] Isoxsuprine Isoxsuprine | [2] Isoxsuprine hydrochloride
Isoxsuprine hydrochloride
,
Isoxsuprine
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 1130 | Isoxsuprine Hydrochloride | [1] Isoxsuprine Isoxsuprine | [2] Isoxsuprine hydrochloride
Isoxsuprine hydrochloride
,
Isoxsuprine
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 1131 | Isradipine | [1] Isradipine Isradipine | [1] Isradipine
Isradipine
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 1132 | Isradipine CR 10mg | [1] Isradipine Isradipine | [1] Isradipine
Isradipine
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 1133 | Isradipine CR 20mg | [1] Isradipine Isradipine | [1] Isradipine
Isradipine
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 1134 | Isradipine CR 5mg | [1] Isradipine Isradipine | [1] Isradipine
Isradipine
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 1135 | IST (ATG + CsA) | - | - | - | - | [1] 60 60 💬
|
| 1136 | ISTEM-01 | - | - | - | - | [1] 90 90 💬
|
| 1137 | ISTIN | - | - | - | - | [1] 67 67 💬
|
| 1138 | ISTRADEFYLLINE | [1] Istradefylline Istradefylline | [1] Istradefylline
Istradefylline
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1139 | Istradefylline ( KW-6002) | [1] Istradefylline Istradefylline | [1] Istradefylline
Istradefylline
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1140 | Istradefylline (KW-6002) | [1] Istradefylline Istradefylline | [1] Istradefylline
Istradefylline
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1141 | Istradefylline 20 mg | [1] Istradefylline Istradefylline | [1] Istradefylline
Istradefylline
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1142 | Istradefylline 20 mg or 40 mg | [1] Istradefylline Istradefylline | [1] Istradefylline
Istradefylline
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1143 | Istradefylline 40 mg | [1] Istradefylline Istradefylline | [1] Istradefylline
Istradefylline
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1144 | Istradefylline medication | [1] Istradefylline Istradefylline | [1] Istradefylline
Istradefylline
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1145 | Istradefylline Pill | [1] Istradefylline Istradefylline | [1] Istradefylline
Istradefylline
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1146 | Isturisa | - | - | - | - | [1] 75 75 💬
|
| 1147 | Isturisa ® | - | - | - | - | [1] 75 75 💬
|
| 1148 | ISU302 | - | - | - | - | [1] 19 19 💬
|
| 1149 | It is a chimera of a Dopamin 2 and an Somatostatin 2 receptor agonist | [1] Somatostatin Somatostatin | [1] Somatostatin
Somatostatin
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1150 | Itacitinib | [1] Itacitinib Itacitinib | [2] Itacitinib
Itacitinib
,
Itacitinib adipate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [4] 46 46, 51, 97, 228 💬
|
| 1151 | ITACITINIB ADIPATE | [1] Itacitinib Itacitinib | [2] Itacitinib
Itacitinib
,
Itacitinib adipate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 97 97, 228 💬
|
| 1152 | Itepekimab | [1] Itepekimab Itepekimab | [1] Itepekimab
Itepekimab
💬
| [1] IL33 IL33 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Influenza A, Necroptosis 💬 | [1] 299 299 💬
|
| 1153 | Itepekimab (SAR440340) | [1] Itepekimab Itepekimab | [1] Itepekimab
Itepekimab
💬
| [1] IL33 IL33 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Influenza A, Necroptosis 💬 | [1] 299 299 💬
|
| 1154 | ITF 2357 | - | - | - | - | [1] 96 96 💬
|
| 1155 | ITF2357 | - | - | - | - | [4] 96 96, 107, 113, 267 💬
|
| 1156 | ITF2357 10 mg/mL | - | - | - | - | [1] 113 113 💬
|
| 1157 | ITF2984 | - | - | - | - | [1] 77 77 💬
|
| 1158 | ITF2984 1000 mcg | - | - | - | - | [1] 77 77 💬
|
| 1159 | ITF2984 2000 mcg | - | - | - | - | [1] 77 77 💬
|
| 1160 | ITF2984 500 mcg | - | - | - | - | [1] 77 77 💬
|
| 1161 | ITF2984 diacetate | - | - | - | - | [1] 77 77 💬
|
| 1162 | ITI-214 | - | - | - | - | [1] 6 6 💬
|
| 1163 | Iticitinib | - | - | - | - | [1] 60 60 💬
|
| 1164 | ITIS diet | - | - | - | - | [1] 46 46 💬
|
| 1165 | Itolizumab | [1] Itolizumab Itolizumab | [1] Itolizumab
Itolizumab
💬
| [1] CD6 CD6 💬
| [1] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction 💬 | [2] 49 49, 50 💬
|
| 1166 | Itolizumab [Bmab 600] | [1] Itolizumab Itolizumab | [1] Itolizumab
Itolizumab
💬
| [1] CD6 CD6 💬
| [1] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction 💬 | [1] 49 49 💬
|
| 1167 | Itraconazole | [1] Itraconazole Itraconazole | [1] Itraconazole
Itraconazole
💬
| - | - | [13] 2 2, 3, 6, 46, 65, 67, 96, 97, 137, 158, 227, 299, 309 💬
|
| 1168 | Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally. | [2] Itraconazole Itraconazole, Terbinafine | [3] Itraconazole
Itraconazole
,
Terbinafine hydrochloride
,
Terbinafine
💬
| - | - | [1] 96 96 💬
|
| 1169 | Itraconazole 65 MG | [1] Itraconazole Itraconazole | [1] Itraconazole
Itraconazole
💬
| - | - | [1] 299 299 💬
|
| 1170 | Itraconazole/voriconazole | [2] Itraconazole Itraconazole, Voriconazole | [2] Itraconazole
Itraconazole
,
Voriconazole
💬
| - | - | [1] 299 299 💬
|
| 1171 | Itraconazole? SHR0302 tablets | [1] Itraconazole Itraconazole | [1] Itraconazole
Itraconazole
💬
| - | - | [1] 46 46 💬
|
| 1172 | IUHSCT for FA-affected fetuses | - | - | - | - | [1] 285 285 💬
|
| 1173 | IUPAC | - | - | - | - | [1] 72 72 💬
|
| 1174 | IUPAC name: 1-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one | - | - | - | - | [1] 17 17 💬
|
| 1175 | IUPAC name: 2-[4-[(2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylam ino]benzoyl]amino | - | - | - | - | [1] 337 337 💬
|
| 1176 | IV Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 1177 | IV administration of CG-BM1 | - | - | - | - | [1] 271 271 💬
|
| 1178 | IV administration of Genetically Engineered Hematopoietic Stem/Progenitors Cells (HSPCs) | - | - | - | - | [1] 285 285 💬
|
| 1179 | IV amikacin | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 1180 | IV Apomorphine | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1181 | IV ceftazidime | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | [1] 299 299 💬
|
| 1182 | IV Corticosteroid | - | - | - | - | [1] 97 97 💬
|
| 1183 | IV Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 51 51 💬
|
| 1184 | IV Deployment Of cSVF In Sterile Normal Saline IV Solution | - | - | - | - | [2] 85 85, 229 💬
|
| 1185 | IV efgartigimod | - | - | - | - | [1] 11 11 💬
|
| 1186 | IV glucose tolerance test | - | - | - | - | [1] 299 299 💬
|
| 1187 | IV golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 1188 | IV infusion | - | - | - | - | [1] 113 113 💬
|
| 1189 | IV Levodopa | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1190 | IV meropenem | [1] Meropenem Meropenem | [2] Meropenem
Meropenem
,
Meropenem
💬
| - | - | [1] 299 299 💬
|
| 1191 | IV methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 1192 | IV methylprednisolone (steroids) | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 1193 | IV migalastat HCl | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 1194 | IV piperacillin-tazobactam | [2] Piperacillin Piperacillin, Tazobactam | [5] Piperacillin sodium
Piperacillin sodium
,
Tazobactam
,
Piperacillin
,
Tazobactam sodium
,
Piperacillin
💬
| - | - | [1] 299 299 💬
|
| 1195 | IV ticarcillin-clavulanate | [1] Ticarcillin Ticarcillin | [2] Ticarcillin disodium
Ticarcillin disodium
,
Ticarcillin
💬
| - | - | [1] 299 299 💬
|
| 1196 | IV tobramycin | [1] Tobramycin Tobramycin | [2] Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | [1] 299 299 💬
|
| 1197 | IV treatment with IGSC, 10% | - | - | - | - | [1] 65 65 💬
|
| 1198 | IV Tulisokibart | [1] Tulisokibart Tulisokibart | [1] Tulisokibart
Tulisokibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [2] 96 96, 97 💬
|
| 1199 | IV vancomycin hydrochloride | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [1] 299 299 💬
|
| 1200 | IVA | - | - | - | - | [1] 299 299 💬
|
| 1201 | IVA 336 | - | - | - | - | [1] 19 19 💬
|
| 1202 | IVA337 | - | - | - | - | [1] 51 51 💬
|
| 1203 | IVABRADINE | [1] Ivabradine Ivabradine | [2] Ivabradine
Ivabradine
,
Ivabradine hydrochloride
💬
| [4] HCN1 HCN1, HCN2, HCN3, HCN4 💬
| [3] GnRH secretion GnRH secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 57 57 💬
|
| 1204 | Ivabradine 5Mg Tab | [1] Ivabradine Ivabradine | [2] Ivabradine
Ivabradine
,
Ivabradine hydrochloride
💬
| [4] HCN1 HCN1, HCN2, HCN3, HCN4 💬
| [3] GnRH secretion GnRH secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 57 57 💬
|
| 1205 | Ivacaftor | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [3] 298 298, 299, 340 💬
|
| 1206 | Ivacaftor (proposed INN) | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1207 | Ivacaftor 125mg tablet | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1208 | Ivacaftor 150 mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1209 | Ivacaftor 150 MG (milligrams) | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [2] 298 298, 299 💬
|
| 1210 | Ivacaftor 150 mg or 250 mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1211 | Ivacaftor 25 mg/75 mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1212 | IVACAFTOR 59,5mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1213 | IVACAFTOR 59.5mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1214 | Ivacaftor 75 mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1215 | Ivacaftor 75 mg/150 mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1216 | IVACAFTOR 75mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1217 | Ivacaftor and Symdeko | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1218 | Ivacaftor Exposed | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1219 | Ivacaftor or elexacaftor/tezacaftor/ivacaftor | [3] Elexacaftor Elexacaftor, Ivacaftor, Tezacaftor | [3] Ivacaftor
Ivacaftor
,
Tezacaftor
,
Elexacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1220 | Ivacaftor+lumacaftor | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1221 | Ivacaftor/Ataluren | [2] Ataluren Ataluren, Ivacaftor | [2] Ataluren
Ataluren
,
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1222 | Ivacaftor/Kalydeco | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1223 | Ivarmacitinib | [1] Ivarmacitinib Ivarmacitinib | [2] Ivarmacitinib
Ivarmacitinib
,
Ivarmacitinib sulfate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [6] 40 40, 46, 51, 56, 271, 300 💬
|
| 1224 | IVIG | - | - | - | - | [8] 11 11, 13, 14, 18, 51, 63, 65, 172 💬
|
| 1225 | IVIG (Intravenous Immunoglobulin) | - | - | - | - | [2] 11 11, 14 💬
|
| 1226 | IVIG infusion | - | - | - | - | [1] 63 63 💬
|
| 1227 | IVIG+IVMP | - | - | - | - | [1] 13 13 💬
|
| 1228 | IVIG-Immuglo | - | - | - | - | [1] 65 65 💬
|
| 1229 | IVIG-L | - | - | - | - | [1] 63 63 💬
|
| 1230 | IVIG-PEG | - | - | - | - | [1] 65 65 💬
|
| 1231 | IVIG-VImmune | - | - | - | - | [1] 65 65 💬
|
| 1232 | IVL3004 | - | - | - | - | [1] 13 13 💬
|
| 1233 | IVL4002 | - | - | - | - | [1] 13 13 💬
|
| 1234 | IVMP | - | - | - | - | [1] 13 13 💬
|
| 1235 | IW-3300 rectal foam | - | - | - | - | [1] 226 226 💬
|
| 1236 | IW-6463 Tablets | - | - | - | - | [1] 21 21 💬
|
| 1237 | IW001 | - | - | - | - | [1] 85 85 💬
|
| 1238 | Ixazomib | [1] Ixazomib Ixazomib | [2] Ixazomib
Ixazomib
,
Ixazomib citrate
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [4] 13 13, 16, 28, 51 💬
|
| 1239 | Ixazomib (NINLARO®) capsules | [1] Ixazomib Ixazomib | [2] Ixazomib
Ixazomib
,
Ixazomib citrate
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 13 13 💬
|
| 1240 | Ixazomib Citrate | [1] Ixazomib Ixazomib | [2] Ixazomib
Ixazomib
,
Ixazomib citrate
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [2] 16 16, 28 💬
|
| 1241 | Ixekizumab | [1] Ixekizumab Ixekizumab | [1] Ixekizumab
Ixekizumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [8] 36 36, 37, 46, 107, 160, 162, 269, 271 💬
|
| 1242 | Ixmyelocel-T | [1] Ixmyelocel-T Ixmyelocel-T | [1] Ixmyelocel-T
Ixmyelocel-T
💬
| - | - | [2] 57 57, 71 💬
|
| 1243 | IXP | - | - | - | - | [1] 222 222 💬
|
| 1244 | IZCARGO | - | - | - | - | [1] 19 19 💬
|
| 1245 | IZD174 | - | - | - | - | [2] 6 6, 106 💬
|
| 1246 | IZD334 | - | - | - | - | [1] 106 106 💬
|
| 1247 | IZINOVA | - | - | - | - | [1] 97 97 💬
|